Stock | Market Cap |
Dividend Yield | P/E Ratio | Dividend Frequency |
Years Paying |
DGR |
000403.SZ PACIFIC SHUANGLIN
|
2.2 billion |
0.92% |
19.19
|
- |
3 |
-
|
000990.SZ CHENGZHI CO. LTD.
|
1.2 billion |
0.00% |
33.50
|
- |
2 |
-
|
002007.SZ HUALAN BIOLOGICA.E
|
4.2 billion |
1.74% |
22.03
|
- |
16 |
2%
|
002030.SZ DAAN GENE CO LTD
|
1.0 billion |
0.00% |
-10.17
|
- |
20 |
25%
|
002252.SZ S/H RAAS BLOOD PRO
|
6.8 billion |
0.00% |
26.89
|
- |
5 |
30%
|
002286.SZ BAOLINGBAO BIOLOGY
|
360.8 million |
1.29% |
23.73
|
1 |
13 |
28%
|
002287.SZ TIBET CHEEZHENG TI
|
1.5 billion |
2.26% |
18.94
|
- |
16 |
-
|
002566.SZ JILIN JIAN YISHENG
|
296.6 million |
0.02% |
29.73
|
1 |
5 |
-
|
002653.SZ HAISCO PHARMACEUTI
|
4.9 billion |
0.01% |
73.98
|
1 |
2 |
-
|
002873.SZ GUIYANG XINTIAN PH
|
290.6 million |
0.76% |
39.87
|
- |
7 |
26%
|
002880.SZ SHENZHEN WEIGUANG
|
862.2 million |
0.75% |
25.22
|
1 |
7 |
-
|
003020.SZ HEFEI LIFEON PHARM
|
460.0 million |
0.02% |
19.64
|
- |
5 |
-
|
005250.KS GCH Corp
|
419.8 million |
- |
-
|
- |
19 |
-4%
|
048530.KQ iNtRON Bio
|
87.3 million |
- |
-
|
- |
2 |
-
|
064550.KQ BIONEER
|
269.3 million |
0.00% |
-
|
- |
- |
-
|
068270.KS Celltrion
|
26.1 billion |
0.39% |
41.11
|
1 |
4 |
-
|
083790.KQ CGIC
|
114.9 million |
0.00% |
-
|
- |
- |
-
|
084990.KQ Helixmith
|
76.8 million |
0.00% |
-
|
- |
- |
-
|
087010.KQ PEPTRON
|
1.7 billion |
0.00% |
-
|
- |
- |
-
|
095700.KQ Genexine
|
121.5 million |
0.00% |
-
|
- |
- |
-
|
096530.KQ SEEGENE
|
736.8 million |
3.25% |
-
|
3 |
7 |
9%
|
1177.HK SINO BIOPHARM
|
9.2 billion |
1.85% |
35.36
|
4 |
22 |
10%
|
1295.TWO SYNBIO
|
71.3 million |
0.00% |
13.70
|
- |
2 |
-
|
1530.HK 3SBIO
|
4.0 billion |
0.04% |
14.51
|
- |
4 |
-
|
1733.TW APEX BIOTECHNOLOGY CORP
|
91.7 million |
0.03% |
28.70
|
1 |
22 |
-
|
1734.TW SINPHAR PHARMACEUTICAL CO LTD
|
172.9 million |
0.03% |
18.48
|
- |
23 |
30%
|
1760.TW PANION & BF BIOTECH INC
|
197.7 million |
1.62% |
51.72
|
- |
10 |
-
|
1762.TW CHUNGHWA CHEMICAL SYNTHESIS BIO
|
79.6 million |
0.00% |
26.51
|
- |
15 |
-8%
|
177A.T KOHJIN BIO CO LTD
|
57.4 million |
0.80% |
17.28
|
- |
- |
-
|
206A.T PRISM BIOLAB CO LTD
|
64.2 million |
- |
-7.45
|
- |
- |
-
|
216080.KQ JETEMA
|
187.5 million |
0.00% |
-
|
- |
- |
-
|
2183.T LINICAL CO LTD
|
46.2 million |
0.00% |
-57.51
|
1 |
17 |
16%
|
226950.KQ OliX
|
543.5 million |
0.00% |
-
|
- |
- |
-
|
2342.T TRANSGENIC GROUP INC
|
20.6 million |
1.60% |
-12.93
|
- |
4 |
-
|
235980.KQ MedPacto
|
74.1 million |
0.00% |
-
|
- |
- |
-
|
2385.T SOIKEN HOLDINGS INC
|
23.5 million |
0.03% |
-8.43
|
- |
8 |
5%
|
299660.KQ Cellid
|
50.4 million |
0.00% |
-
|
- |
- |
-
|
300009.SZ ANHUI ANKE BIOTECH
|
1.9 billion |
0.03% |
17.79
|
- |
16 |
14%
|
300122.SZ CHONGQING ZHIFEI B
|
8.6 billion |
0.03% |
16.08
|
- |
14 |
20%
|
300181.SZ ZHEJIANG JOLLY PHA
|
1.4 billion |
0.03% |
20.27
|
1 |
13 |
30%
|
300294.SZ CHINA RESOURCES BO
|
2.0 billion |
1.38% |
80.08
|
- |
13 |
30%
|
300381.SZ GUANGDONG VTR BIO-
|
433.6 million |
0.01% |
164.75
|
- |
11 |
-
|
300583.SZ SHANDONG SITO BIO
|
501.7 million |
0.04% |
-113.53
|
- |
3 |
-
|
300653.SZ YANTAI ZHENGHAI BI
|
491.5 million |
0.04% |
21.51
|
- |
7 |
30%
|
300841.SZ Chengdu Kanghua Biological Products Co., Ltd.
|
910.0 million |
- |
12.57
|
1 |
4 |
-
|
300871.SZ HVSEN BIOTECHNOLOG
|
213.7 million |
0.02% |
-33.75
|
- |
4 |
-
|
300878.SZ ZHEJIANG WECOME PH
|
280.9 million |
0.01% |
-62.74
|
- |
1 |
-
|
300966.SZ HUBEI GOTO BIOPHAR
|
241.1 million |
0.00% |
-127.17
|
- |
1 |
-
|
301207.SZ HUALAN BIOLOGICAL
|
1.4 billion |
0.03% |
20.51
|
- |
3 |
-
|
3164.TW GENMONT BIOTECH INC
|
53.3 million |
0.00% |
32.87
|
- |
6 |
11%
|
3759.HK PHARMARON
|
5.7 billion |
0.02% |
11.50
|
- |
5 |
-
|
4130.TWO GENOVATE BIOTECHNOLOGY CO. LTD.
|
74.1 million |
0.01% |
93.91
|
- |
12 |
-9%
|
4133.TW ABNOVA (TAIWAN) CORPORATION
|
55.9 million |
0.02% |
30.98
|
- |
15 |
-
|
4162.TWO PHARMAENGINE INC
|
436.4 million |
1.38% |
8.12
|
- |
10 |
30%
|
4167.TWO SAVIOR LIFETEC CORPORATION
|
191.3 million |
0.00% |
34.39
|
- |
2 |
-
|
4169.TWO TCM
|
102.2 million |
0.01% |
165.59
|
1 |
2 |
-
|
4732.TWO NBM
|
38.3 million |
0.00% |
93.52
|
1 |
4 |
-
|
4880.T CELLSOURCE CO LTD
|
97.4 million |
0.00% |
58.58
|
- |
3 |
-
|
4911.TWO G&E HERBAL BIOTECHNOLOGY CO. LT
|
99.2 million |
0.01% |
31.62
|
1 |
1 |
-
|
4974.T TAKARA BIO INC
|
658.0 million |
1.65% |
-1945
|
1 |
14 |
30%
|
600161.SS BEIJING TIANTAN BIOLOGICAL PROD
|
5.4 billion |
0.00% |
31.08
|
- |
- |
-
|
600201.SS JINYU BIO-TECHNOLOGY CO LTD
|
983.6 million |
0.01% |
43.53
|
- |
13 |
-3%
|
600866.SS STAR LAKE BIOSCIENCE CO INC Z
|
1.4 billion |
0.06% |
11.83
|
- |
- |
-
|
603233.SS DASHENLIN PHARMACEUTICAL GROUP
|
2.2 billion |
4.26% |
19.17
|
- |
7 |
4%
|
603392.SS BEIJING WANTAI BIOLOGICAL PHARM
|
12.2 billion |
0.00% |
-307.30
|
- |
4 |
-
|
603439.SS GUIZHOU SANLI PHARMACEUTICAL CO
|
697.4 million |
0.01% |
15.84
|
- |
2 |
-
|
603566.SS PULIKE BIOLOGICAL
|
570.6 million |
0.05% |
41.79
|
- |
- |
-
|
603718.SS SHANGHAI HILE BIO-
|
570.1 million |
0.00% |
646
|
- |
2 |
-
|
603739.SS QINGDAO VLAND BIOTECH CO LTD
|
402.6 million |
0.01% |
44.65
|
- |
6 |
-30%
|
603896.SS ZHEJIANG SHOUXIANGU PHARMACEUTI
|
546.3 million |
0.01% |
16.90
|
- |
7 |
-
|
605116.SS AURISCO PHARMACEUTICAL CO LTD
|
1.1 billion |
0.01% |
24.76
|
- |
4 |
-
|
6712.TWO Ever Supreme Bio Technology Co., Ltd
|
421.3 million |
2.99% |
36.84
|
- |
4 |
-
|
6821.HK ASYMCHEM
|
3.7 billion |
0.03% |
19.36
|
1 |
3 |
-
|
6826.HK HAOHAI BIOTEC
|
1.7 billion |
0.02% |
14.20
|
- |
9 |
30%
|
6846.TWO GREENYN
|
66.5 million |
0.00% |
14.86
|
- |
3 |
-
|
6848.TWO RBC
|
7.6 million |
0.02% |
14.51
|
2 |
3 |
-
|
688075.SS ASSURE TECH (HANGZHOU) CO LTD
|
613.4 million |
0.01% |
49.61
|
- |
3 |
-
|
688076.SS SINOPEP-ALLSINO BIO PHARMACEUTI
|
1.5 billion |
0.01% |
26.32
|
- |
3 |
-
|
688098.SS SHANGHAI SHEN LIAN BIOMEDICAL C
|
289.8 million |
0.01% |
-128.75
|
- |
5 |
-26%
|
688105.SS NANJING VAZYME BIOTECH CO LTD
|
1.2 billion |
0.01% |
359.17
|
- |
3 |
-
|
688278.SS XIAMEN AMOYTOP BIOTECH CO LTD
|
4.1 billion |
0.01% |
40.39
|
1 |
- |
-
|
688366.SS SHANGHAI HAOHAI BIOLOGICAL TECH
|
1.7 billion |
0.01% |
31.77
|
- |
5 |
30%
|
688526.SS WUHAN KEQIAN BIOLOGY CO LTD
|
857.0 million |
0.02% |
21.05
|
1 |
4 |
-
|
688578.SS SHANGHAI ALLIST PHARMACEUTICALS
|
3.6 billion |
0.01% |
20.46
|
- |
1 |
-
|
688639.SS ANHUI HUAHENG BIOTECHNOLOGY CO
|
1.0 billion |
0.01% |
22.68
|
- |
4 |
-
|
688687.SS BEIJING KAWIN TECHNOLOGY SHARE-
|
488.7 million |
0.01% |
26.63
|
1 |
4 |
-
|
688767.SS HANGZHOU BIOTEST BIOTECH CO LTD
|
464.1 million |
0.03% |
32.73
|
- |
4 |
-
|
7096.T STEMCELL INSTITUTE
|
92.8 million |
0.00% |
31.21
|
- |
1 |
-
|
AADI Aadi Bioscience, Inc.
|
94.9 million |
0.00% |
-
|
- |
- |
-
|
ABCL AbCellera Biologics Inc.
|
622.8 million |
0.00% |
-3.80
|
- |
- |
-
|
ABCM Abcam plc
|
5.5 billion |
0.75% |
2397
|
- |
- |
-
|
ABEO Abeona Therapeutics Inc.
|
227.1 million |
0.00% |
-3.02
|
- |
- |
-
|
ABIO ARCA biopharma, Inc.
|
40.8 million |
0.00% |
-4.32
|
- |
1 |
-
|
ABSI Absci Corporation
|
284.6 million |
0.00% |
-2.38
|
- |
- |
-
|
ABUS Arbutus Biopharma Corporation
|
618.5 million |
0.00% |
-8.50
|
- |
- |
-
|
ABVC ABVC Biopharma, Inc.
|
14.3 million |
0.00% |
-1.36
|
- |
- |
-
|
ACAD ACADIA Pharmaceuticals Inc.
|
2.7 billion |
0.00% |
11.85
|
- |
- |
-
|
ACER Acer Therapeutics Inc.
|
16.1 million |
3.50% |
-1.35
|
- |
- |
-
|
ACET Adicet Bio, Inc.
|
56.0 million |
0.00% |
-0.51
|
2 |
- |
-
|
ACHL Achilles Therapeutics plc
|
56.3 million |
0.00% |
-0.83
|
- |
- |
-
|
ACHV Achieve Life Sciences, Inc.
|
75.6 million |
0.00% |
-1.76
|
- |
- |
-
|
ACIU AC Immune SA
|
186.0 million |
0.00% |
-3.24
|
- |
- |
-
|
ACST Acasti Pharma, Inc.
|
33.2 million |
0.00% |
-0.41
|
- |
- |
-
|
ACXP Acurx Pharmaceuticals, Inc.
|
7.9 million |
0.00% |
-0.41
|
- |
- |
-
|
ADAG Adagene Inc.
|
61.8 million |
0.00% |
-2.22
|
- |
- |
-
|
ADAP Adaptimmune Therapeutics plc
|
82.9 million |
0.00% |
-1.08
|
- |
- |
-
|
ADCT ADC Therapeutics SA
|
116.9 million |
0.00% |
-0.73
|
- |
- |
-
|
ADGI Adagio Therapeutics, Inc.
|
505.0 million |
- |
-
|
- |
- |
-
|
ADIL Adial Pharmaceuticals, Inc
|
4.5 million |
0.00% |
-0.25
|
- |
- |
-
|
ADMA ADMA Biologics Inc
|
4.2 billion |
0.00% |
22.04
|
- |
- |
-
|
ADPT Adaptive Biotechnologies Corpor
|
1.1 billion |
0.00% |
-7.05
|
- |
- |
-
|
ADTX Aditxt, Inc.
|
3.0 million |
0.00% |
-
|
- |
- |
-
|
ADVM Adverum Biotechnologies, Inc.
|
80.3 million |
0.00% |
-0.65
|
- |
- |
-
|
ADXN Addex Therapeutics Ltd
|
7.8 million |
0.00% |
-
|
- |
- |
-
|
ADXS Ayala Pharmaceuticals, Inc.
|
1.3 million |
0.00% |
-0.34
|
- |
- |
-
|
AEON
|
- |
- |
-
|
- |
- |
-
|
AEZS Aeterna Zentaris Inc.
|
18.1 million |
0.00% |
-0.37
|
- |
- |
-
|
AFMD Affimed N.V.
|
9.6 million |
0.00% |
-0.13
|
- |
- |
-
|
AGE AgeX Therapeutics, Inc.
|
33.2 million |
0.00% |
-1.02
|
- |
- |
-
|
AGEN Agenus Inc.
|
40.5 million |
0.00% |
-0.15
|
- |
- |
-
|
AGIO Agios Pharmaceuticals, Inc.
|
1.6 billion |
0.00% |
2.44
|
- |
- |
-
|
AGLE Spyre Therapeutics, Inc.
|
48.6 million |
- |
-4.70
|
- |
- |
-
|
AGTC Applied Genetic Technologies Corporation
|
26.6 million |
- |
-2.28
|
- |
- |
-
|
AIKI AIkido Pharma Inc.
|
19.4 million |
- |
-0.24
|
- |
- |
-
|
AIM AIM ImmunoTech Inc.
|
6.5 million |
0.00% |
-
|
- |
- |
-
|
AKRO Akero Therapeutics, Inc.
|
3.2 billion |
0.00% |
-10.66
|
- |
- |
-
|
AKTX Akari Therapeutics Plc
|
13.5 million |
0.00% |
-0.43
|
- |
- |
-
|
AKUS Akouos, Inc.
|
491.0 million |
- |
-
|
- |
- |
-
|
ALBO Albireo Pharma, Inc.
|
920.7 million |
- |
-11.67
|
- |
- |
-
|
ALDX Aldeyra Therapeutics, Inc.
|
84.8 million |
0.00% |
-1.51
|
- |
- |
-
|
ALEC Alector, Inc.
|
116.9 million |
0.00% |
-0.96
|
- |
- |
-
|
ALGS Aligos Therapeutics, Inc.
|
36.4 million |
0.00% |
-0.28
|
- |
- |
-
|
ALK-B.CO ALK-Abelló B A/S
|
4.8 billion |
0.00% |
38.70
|
- |
- |
-
|
ALLK Allakos Inc.
|
28.9 million |
0.00% |
-0.25
|
- |
- |
-
|
ALLO Allogene Therapeutics, Inc.
|
312.9 million |
0.00% |
-1.09
|
- |
- |
-
|
ALLR Allarity Therapeutics, Inc.
|
3.6 million |
0.00% |
0.00
|
- |
- |
-
|
ALNA Allena Pharmaceuticals, Inc.
|
9.2 million |
- |
-1.19
|
- |
- |
-
|
ALNY Alnylam Pharmaceuticals, Inc.
|
34.1 billion |
0.00% |
-119.71
|
- |
- |
-
|
ALPN Alpine Immune Sciences, Inc.
|
4.5 billion |
0.00% |
-22.30
|
- |
- |
-
|
ALRN Aileron Therapeutics, Inc.
|
41.8 million |
0.00% |
-1.64
|
- |
- |
-
|
ALT Altimmune, Inc.
|
343.5 million |
0.00% |
-3.33
|
- |
- |
-
|
ALVR AlloVir, Inc.
|
50.9 million |
0.00% |
-0.50
|
- |
- |
-
|
ALXN Alexion Pharmaceuticals, Inc.
|
40.3 billion |
- |
59.23
|
- |
- |
-
|
ALXO ALX Oncology Holdings Inc.
|
29.1 million |
0.00% |
-0.21
|
- |
- |
-
|
ALZN Alzamend Neuro, Inc.
|
6.5 million |
0.00% |
-0.01
|
- |
- |
-
|
AMAM Ambrx Biopharma Inc.
|
1.8 billion |
0.00% |
66.14
|
- |
- |
-
|
AMLX Amylyx Pharmaceuticals, Inc.
|
311.0 million |
0.00% |
-0.79
|
- |
- |
-
|
AMPE Ampio Pharmaceuticals, Inc.
|
681 |
0.00% |
-0.15
|
- |
- |
-
|
AMTI Applied Molecular Transport Inc.
|
11.0 million |
- |
-0.14
|
- |
- |
-
|
ANAB AnaptysBio, Inc.
|
578.0 million |
- |
68.66
|
- |
- |
-
|
ANEB Anebulo Pharmaceuticals, Inc.
|
44.0 million |
0.00% |
-3.69
|
- |
- |
-
|
ANGN Angion Biomedica Corp.
|
20.4 million |
- |
-
|
- |
- |
-
|
ANIX Anixa Biosciences, Inc.
|
81.5 million |
0.00% |
-6.49
|
- |
- |
-
|
ANNX Annexon, Inc.
|
185.4 million |
0.00% |
-1.67
|
- |
- |
-
|
ANPC Fresh2 Group Limited
|
27.0 million |
- |
-
|
- |
- |
-
|
ANTH Anthera Pharmaceuticals, Inc.
|
6178 |
- |
0.00
|
- |
- |
-
|
ANTX AN2 Therapeutics, Inc.
|
38.2 million |
0.00% |
-0.74
|
3 |
- |
-
|
ANVS Annovis Bio, Inc.
|
26.2 million |
0.00% |
-0.58
|
- |
- |
-
|
APLS Apellis Pharmaceuticals, Inc.
|
2.8 billion |
0.00% |
-14.07
|
- |
- |
-
|
APLT Applied Therapeutics, Inc.
|
50.6 million |
0.00% |
-
|
- |
- |
-
|
APM Aptorum Group Limited
|
7.0 million |
- |
2.70
|
- |
- |
-
|
APOP Cellect Biotechnology Ltd.
|
51.5 million |
- |
-0.82
|
- |
- |
-
|
APRE Aprea Therapeutics, Inc.
|
9.3 million |
0.00% |
-0.72
|
- |
- |
-
|
APTO Aptose Biosciences, Inc.
|
4.4 million |
0.00% |
-0.05
|
- |
- |
-
|
APTX Aptinyx Inc.
|
4.4 million |
- |
-2.48
|
- |
- |
-
|
APVO Aptevo Therapeutics Inc.
|
2.2 million |
0.00% |
-0.02
|
- |
- |
-
|
ARAV Aravive, Inc.
|
2.9 million |
- |
-0.05
|
- |
- |
-
|
ARBS.MI ARTERRA BIOSCIENCE
|
16.4 million |
- |
10.29
|
- |
4 |
-
|
ARCT Arcturus Therapeutics Holdings
|
257.2 million |
0.00% |
-3.16
|
1 |
- |
-
|
ARDS Aridis Pharmaceuticals Inc.
|
4457 |
0.00% |
-
|
- |
- |
-
|
ARDX Ardelyx, Inc.
|
1.1 billion |
0.00% |
-27.50
|
- |
- |
-
|
ARGX argenx SE
|
35.9 billion |
0.00% |
46.27
|
- |
- |
-
|
ARMP Armata Pharmaceuticals, Inc.
|
46.7 million |
0.00% |
-1.45
|
- |
- |
-
|
ARNA Arena Pharmaceuticals, Inc.
|
6.2 billion |
- |
-6.17
|
- |
- |
-
|
ARQT Arcutis Biotherapeutics, Inc.
|
1.9 billion |
0.00% |
-13.80
|
- |
- |
-
|
ARTL Artelo Biosciences, Inc.
|
2.8 million |
0.00% |
-0.28
|
- |
- |
-
|
ARVN Arvinas, Inc.
|
474.5 million |
0.00% |
-2.49
|
- |
- |
-
|
ARWR Arrowhead Pharmaceuticals, Inc.
|
1.7 billion |
0.00% |
-2.34
|
- |
- |
-
|
ASLN ASLAN Pharmaceuticals Limited
|
6.7 million |
0.00% |
-0.19
|
- |
- |
-
|
ASMB Assembly Biosciences, Inc.
|
69.9 million |
0.00% |
-1.39
|
- |
- |
-
|
ASND Ascendis Pharma A/S
|
9.1 billion |
0.00% |
-21.48
|
- |
- |
-
|
ATAI ATAI Life Sciences N.V.
|
274.7 million |
0.00% |
-1.49
|
1 |
- |
-
|
ATHA Athira Pharma, Inc.
|
10.0 million |
0.00% |
-0.10
|
- |
- |
-
|
ATHE Alterity Therapeutics Limited
|
31.0 million |
0.00% |
-1.92
|
- |
- |
-
|
ATHX Athersys, Inc.
|
459479 |
1.02% |
0.72
|
- |
- |
-
|
ATNF 180 Life Sciences Corp.
|
4.6 million |
0.00% |
0.11
|
- |
- |
-
|
ATNFW 180 Life Sciences Corp.
|
12851 |
0.00% |
-
|
- |
- |
-
|
ATNM Actinium Pharmaceuticals, Inc.
|
43.4 million |
0.00% |
-1.09
|
- |
- |
-
|
ATOS Atossa Therapeutics, Inc.
|
85.0 million |
0.00% |
-3.29
|
- |
- |
-
|
ATRA Atara Biotherapeutics, Inc.
|
32.8 million |
0.00% |
-0.49
|
- |
- |
-
|
ATXI Avenue Therapeutics, Inc.
|
556612 |
0.00% |
0.01
|
- |
- |
-
|
ATXS Astria Therapeutics, Inc.
|
290.6 million |
0.00% |
-3.07
|
- |
- |
-
|
AUPH Aurinia Pharmaceuticals Inc
|
1.1 billion |
0.00% |
194.63
|
- |
- |
-
|
AURA Aura Biosciences, Inc.
|
272.7 million |
0.00% |
-3.10
|
- |
- |
-
|
AUTL Autolus Therapeutics plc
|
353.9 million |
0.00% |
-1.55
|
- |
- |
-
|
AVEO AVEO Pharmaceuticals, Inc.
|
521.4 million |
- |
-3.94
|
- |
- |
-
|
AVIR Atea Pharmaceuticals, Inc.
|
246.3 million |
0.00% |
-1.44
|
- |
- |
-
|
AVRO AVROBIO, Inc.
|
68.2 million |
0.00% |
2.20
|
- |
- |
-
|
AVTX Avalo Therapeutics, Inc.
|
70.3 million |
0.00% |
-0.32
|
- |
- |
-
|
AVXL Anavex Life Sciences Corp.
|
696.7 million |
0.00% |
-14.89
|
- |
- |
-
|
AXLA Axcella Health Inc.
|
1.2 million |
- |
-0.02
|
- |
- |
-
|
AXSM Axsome Therapeutics, Inc.
|
5.3 billion |
0.00% |
-18.01
|
- |
- |
-
|
AYLA Ayala Pharmaceuticals, Inc.
|
7.5 million |
- |
-
|
- |
- |
-
|
AZRX AzurRx BioPharma, Inc.
|
271.1 million |
- |
-1.26
|
- |
- |
-
|
BAVA.CO Bavarian Nordic A/S
|
1.7 billion |
0.00% |
11.36
|
- |
- |
-
|
BBI Brickell Biotech, Inc.
|
6.8 million |
- |
-0.60
|
- |
- |
-
|
BBIO BridgeBio Pharma, Inc.
|
6.5 billion |
0.00% |
-11.83
|
- |
- |
-
|
BBZA.DE BB Biotech AG N
|
1.9 billion |
4.90% |
12.69
|
1 |
13 |
-10%
|
BCAB BioAtla, Inc.
|
16.4 million |
0.00% |
-0.19
|
- |
- |
-
|
BCAX Bicara Therapeutics Inc. Common Stock
|
645.0 million |
0.00% |
-2.92
|
- |
- |
-
|
BCDA BioCardia, Inc.
|
10.6 million |
0.00% |
-0.78
|
- |
- |
-
|
BCDAW BioCardia, Inc.
|
4.4 million |
0.00% |
-0.01
|
- |
- |
-
|
BCEL Atreca, Inc.
|
3.6 million |
0.00% |
-0.11
|
- |
- |
-
|
BCLI Brainstorm Cell Therapeutics In
|
8.0 million |
0.00% |
-0.36
|
- |
- |
-
|
BCRX BioCryst Pharmaceuticals, Inc.
|
1.4 billion |
0.00% |
-15.88
|
- |
- |
-
|
BCTX BriaCell Therapeutics Corp.
|
14.6 million |
0.00% |
-0.83
|
- |
- |
-
|
BCTXW BriaCell Therapeutics Corp.
|
370461 |
0.00% |
-
|
- |
- |
-
|
BCYC Bicycle Therapeutics plc
|
513.1 million |
0.00% |
-2.56
|
- |
- |
-
|
BDTX Black Diamond Therapeutics, Inc
|
85.6 million |
0.00% |
-1.19
|
- |
- |
-
|
BEAM Beam Therapeutics Inc.
|
1.6 billion |
0.00% |
-3.59
|
4 |
- |
-
|
BFRA Biofrontera AG
|
80.2 million |
- |
-8.15
|
- |
- |
-
|
BGBIO.OL BERGENBIO
|
5.8 million |
0.00% |
-0.40
|
- |
- |
-
|
BGNE BeiGene, Ltd.
|
20.2 billion |
0.00% |
-
|
- |
- |
-
|
BHVN Biohaven Ltd.
|
1.9 billion |
0.00% |
-2.06
|
- |
- |
-
|
BIO3.DE BIOTEST AG VZ O.N.
|
1.6 billion |
0.00% |
17.34
|
1 |
1 |
-
|
BIOCON.BO BIOCON LTD.
|
4.6 billion |
0.14% |
48.95
|
- |
3 |
-
|
BIOCON.NS BIOCON LTD
|
4.6 billion |
0.14% |
48.93
|
- |
3 |
-
|
BIO.DE BIOTEST AG ST O.N.
|
1.6 billion |
0.00% |
24.62
|
1 |
1 |
-
|
BION.SW BB BIOTECH N
|
1.8 billion |
5.16% |
12.03
|
1 |
13 |
-6%
|
BIVI BioVie Inc.
|
16.2 million |
0.00% |
-0.27
|
- |
- |
-
|
BLCM Bellicum Pharmaceuticals, Inc.
|
778326 |
0.00% |
-0.13
|
- |
- |
-
|
BLI Berkeley Lights, Inc.
|
86.6 million |
- |
-
|
- |
- |
-
|
BLPH Bellerophon Therapeutics, Inc.
|
232419 |
0.00% |
-0.07
|
- |
- |
-
|
BLRX BioLineRx Ltd.
|
10.9 million |
0.00% |
-
|
- |
- |
-
|
BLU BELLUS Health Inc.
|
1.8 billion |
- |
-4.06
|
- |
- |
-
|
BLUE bluebird bio, Inc.
|
47.9 million |
0.00% |
-0.20
|
- |
- |
-
|
BLUEJET.BO Blue Jet Healthcare Limited
|
1.5 billion |
0.00% |
53.69
|
- |
1 |
-
|
BLUEJET.NS BLUE JET HEALTHCARE LTD
|
1.5 billion |
0.00% |
53.48
|
- |
1 |
-
|
BMEA Biomea Fusion, Inc.
|
73.3 million |
0.00% |
-0.49
|
- |
- |
-
|
BMRN BioMarin Pharmaceutical Inc.
|
12.9 billion |
0.00% |
30.53
|
- |
- |
-
|
BNOX Bionomics Limited - American De
|
6.3 million |
0.00% |
-0.38
|
- |
- |
-
|
BNTC Benitec Biopharma Inc.
|
305.1 million |
0.00% |
-20.98
|
- |
- |
-
|
BNTX BioNTech SE
|
22.1 billion |
0.00% |
-30.67
|
- |
- |
-
|
BOLT Bolt Biotherapeutics, Inc.
|
13.8 million |
0.00% |
-0.22
|
4 |
- |
-
|
BOT.AX BOTANIX FPO [BOT]
|
497.6 million |
0.00% |
-21.25
|
- |
- |
-
|
BPMC Blueprint Medicines Corporation
|
5.6 billion |
0.00% |
-82.19
|
- |
- |
-
|
BPTH Bio-Path Holdings, Inc.
|
1.3 million |
0.00% |
-0.04
|
- |
- |
-
|
BRAX.CN BraxiaScience
|
1.0 million |
0.00% |
-0.10
|
- |
- |
-
|
BRNS Barinthus Biotherapeutics plc
|
30.6 million |
- |
-0.49
|
- |
- |
-
|
BRTX BioRestorative Therapies, Inc.
|
12.8 million |
0.00% |
-1.47
|
- |
- |
-
|
BSTG Harvard Apparatus Regenerative Technology Inc.
|
81.3 million |
- |
-2.69
|
- |
- |
-
|
BTAI BioXcel Therapeutics, Inc.
|
8.7 million |
0.00% |
-0.07
|
- |
- |
-
|
BTTX Better Therapeutics, Inc.
|
21806 |
0.00% |
-
|
- |
- |
-
|
BTX Eterna Therapeutics Inc.
|
12.0 million |
- |
17.81
|
- |
- |
-
|
BVXP.L BIOVENTIX PLC ORD 5P
|
1.6 million |
0.05% |
15.86
|
2 |
12 |
20%
|
BVXV BiondVax Pharmaceuticals Ltd.
|
6.3 million |
- |
-0.95
|
- |
- |
-
|
BYSI BeyondSpring, Inc.
|
60.5 million |
0.00% |
-7.14
|
- |
- |
-
|
CABA Cabaletta Bio, Inc.
|
61.1 million |
0.00% |
-0.51
|
- |
- |
-
|
CADL Candel Therapeutics, Inc.
|
227.7 million |
0.00% |
-2.77
|
- |
- |
-
|
CALA Calithera Biosciences, Inc.
|
487 |
0.00% |
-3.31
|
- |
- |
-
|
CALT Calliditas Therapeutics AB
|
1.1 billion |
0.00% |
-
|
- |
- |
-
|
CAMP CAMP4 THERAPEUTICS CORPORATION
|
61.1 million |
0.00% |
-0.27
|
- |
- |
-
|
CANF Can-Fite Biopharma Ltd Sponsore
|
12.4 million |
0.00% |
-
|
- |
- |
-
|
CAPR Capricor Therapeutics, Inc.
|
423.4 million |
0.00% |
-8.06
|
- |
- |
-
|
CARA Cara Therapeutics, Inc.
|
22.6 million |
0.00% |
-0.32
|
- |
- |
-
|
CARM Carisma Therapeutics, Inc.
|
8.7 million |
0.00% |
-
|
- |
- |
-
|
CASI CASI Pharmaceuticals, Inc.
|
32.4 million |
0.00% |
-0.82
|
- |
- |
-
|
CATB Catabasis Pharmaceuticals, Inc.
|
657.1 million |
- |
-0.66
|
- |
- |
-
|
CBAY CymaBay Therapeutics, Inc.
|
3.7 billion |
0.00% |
-34.58
|
- |
- |
-
|
CBIO Catalyst Biosciences, Inc.
|
19.4 million |
792.92% |
1.67
|
- |
- |
-
|
CBLI Cleveland BioLabs, Inc.
|
49.0 million |
0.00% |
-16.82
|
- |
- |
-
|
CCCC C4 Therapeutics, Inc.
|
93.0 million |
0.00% |
-0.86
|
- |
- |
-
|
CCXI ChemoCentryx, Inc.
|
3.7 billion |
4.97% |
-91.33
|
- |
- |
-
|
CDAK Codiak BioSciences, Inc.
|
2.8 million |
- |
-
|
- |
- |
-
|
CDMO Avid Bioservices, Inc.
|
798.9 million |
0.00% |
-
|
- |
- |
-
|
CDMOP Avid Bioservices, Inc.
|
205.1 million |
10.10% |
-
|
3 |
- |
-
|
CDTX Cidara Therapeutics, Inc.
|
195.2 million |
0.00% |
-0.66
|
- |
- |
-
|
CDXS Codexis, Inc.
|
176.0 million |
0.00% |
-2.39
|
- |
- |
-
|
CELC Celcuity Inc.
|
327.3 million |
0.00% |
-3.06
|
- |
- |
-
|
CELU Celularity Inc.
|
36.4 million |
0.00% |
-0.02
|
- |
- |
-
|
CELUW Celularity Inc.
|
37.3 million |
0.00% |
-0.05
|
- |
- |
-
|
CELZ Creative Medical Technology Hol
|
5.4 million |
0.00% |
-0.58
|
- |
- |
-
|
CERE Cerevel Therapeutics Holdings,
|
7.5 billion |
0.00% |
-17.17
|
- |
- |
-
|
CFRX ContraFect Corporation
|
267940 |
- |
-2.36
|
- |
- |
-
|
CGEM Cullinan Therapeutics, Inc.
|
438.3 million |
0.00% |
-2.69
|
- |
- |
-
|
CGEN Compugen Ltd.
|
122.5 million |
0.00% |
-8.19
|
- |
- |
-
|
CGTX Cognition Therapeutics, Inc.
|
23.9 million |
0.00% |
-0.45
|
- |
- |
-
|
CHRS Coherus BioSciences, Inc.
|
105.5 million |
0.00% |
3.64
|
- |
- |
-
|
CINC CinCor Pharma, Inc.
|
1.3 billion |
- |
-
|
- |
- |
-
|
CING Cingulate Inc.
|
15.7 million |
0.00% |
-0.41
|
- |
- |
-
|
CINGW Cingulate Inc. Warrants
|
134909 |
0.00% |
-0.02
|
- |
- |
-
|
CKPT Checkpoint Therapeutics, Inc.
|
335.6 million |
0.00% |
-2.85
|
- |
- |
-
|
CLBS Caladrius Biosciences, Inc.
|
25.8 million |
- |
-2.40
|
- |
- |
-
|
CLDX Celldex Therapeutics, Inc.
|
1.1 billion |
0.00% |
-7
|
- |
- |
-
|
CLGN CollPlant Biotechnologies Ltd.
|
28.2 million |
0.00% |
-1.70
|
- |
- |
-
|
CLLS Cellectis S.A.
|
120.1 million |
0.00% |
-2.93
|
- |
- |
-
|
CLRB Cellectar Biosciences, Inc.
|
12.2 million |
0.00% |
-0.19
|
- |
- |
-
|
CLSD Clearside Biomedical, Inc.
|
66.4 million |
0.00% |
-1.83
|
- |
- |
-
|
CLSN Imunon, Inc.
|
13.9 million |
- |
-2.12
|
- |
- |
-
|
CLVLF Clinuvel Pharmaceuticals Ltd.
|
373.0 million |
- |
15.52
|
1 |
7 |
30%
|
CLVLY Clinuvel Pharmaceuticals Ltd.
|
360.4 million |
0.70% |
15
|
1 |
7 |
20%
|
CLVS Clovis Oncology, Inc.
|
34.8 million |
0.92% |
-1.42
|
- |
- |
-
|
CLXT Calyxt, Inc.
|
31.3 million |
- |
-3.73
|
- |
- |
-
|
CMMB Chemomab Therapeutics Ltd.
|
1.0 million |
0.00% |
-1.24
|
- |
- |
-
|
CMPI Checkmate Pharmaceuticals, Inc.
|
227.1 million |
- |
-
|
- |
- |
-
|
CMRX Chimerix, Inc.
|
800.1 million |
0.00% |
-8.62
|
- |
- |
-
|
CMXHF CSL LTD
|
78.3 billion |
1.34% |
29.68
|
2 |
22 |
0%
|
CNCE Concert Pharmaceuticals, Inc.
|
403.4 million |
- |
-4.28
|
- |
- |
-
|
CNSP CNS Pharmaceuticals, Inc.
|
3.7 million |
0.00% |
-0.04
|
- |
- |
-
|
CNST Constellation Pharmaceuticals, Inc.
|
1.6 billion |
- |
-7.75
|
- |
- |
-
|
CNTA Centessa Pharmaceuticals plc
|
1.7 billion |
0.00% |
-6.34
|
- |
- |
-
|
CNTB Connect Biopharma Holdings Limi
|
34.8 million |
0.00% |
-1.62
|
- |
- |
-
|
COCP Cocrystal Pharma, Inc.
|
14.4 million |
0.00% |
-0.83
|
- |
- |
-
|
COGT Cogent Biosciences, Inc.
|
612.5 million |
0.00% |
-2.77
|
- |
- |
-
|
CONCORDBIO.BO Concord Biotech Limited
|
2.0 billion |
0.00% |
53.19
|
- |
1 |
-
|
CONCORDBIO.NS Concord Biotech Limited
|
2.1 billion |
0.00% |
55.12
|
- |
1 |
-
|
CORT Corcept Therapeutics Incorporat
|
7.9 billion |
0.00% |
60.53
|
- |
- |
-
|
COYA Coya Therapeutics, Inc.
|
102.0 million |
0.00% |
-6.22
|
- |
- |
-
|
CPRX Catalyst Pharmaceuticals, Inc.
|
2.8 billion |
0.00% |
17.61
|
- |
- |
-
|
CRBP Corbus Pharmaceuticals Holdings
|
63.6 million |
0.00% |
-1.41
|
- |
- |
-
|
CRBU Caribou Biosciences, Inc.
|
80.1 million |
0.00% |
-0.52
|
- |
- |
-
|
CRDF Cardiff Oncology, Inc.
|
190.9 million |
0.00% |
-3.02
|
- |
- |
-
|
CRIS Curis, Inc.
|
12.5 million |
0.00% |
-
|
- |
- |
-
|
CRMD CorMedix Inc.
|
397.6 million |
0.00% |
-20.33
|
- |
- |
-
|
CRNX Crinetics Pharmaceuticals, Inc.
|
2.5 billion |
0.00% |
-7.29
|
- |
- |
-
|
CRSP CRISPR Therapeutics AG
|
2.9 billion |
0.00% |
-7.88
|
- |
- |
-
|
CRTX Cortexyme, Inc.
|
58.3 million |
- |
-20.13
|
- |
- |
-
|
CRVS Corvus Pharmaceuticals, Inc.
|
194.2 million |
0.00% |
-2.79
|
- |
- |
-
|
CSBR Champions Oncology, Inc.
|
117.5 million |
0.00% |
18.89
|
- |
- |
-
|
CSCI.TO COSCIENS BIOPHARMA INC
|
9.4 million |
0.00% |
-
|
- |
- |
-
|
CSL.AX CSL FPO [CSL]
|
78.4 billion |
0.00% |
29.25
|
2 |
32 |
10%
|
CSLLY CSL Ltd.
|
78.4 billion |
3.09% |
29.64
|
2 |
17 |
6%
|
CTIC CTI BioPharma Corp.
|
646.2 million |
- |
-3.92
|
- |
- |
-
|
CTMX CytomX Therapeutics, Inc.
|
45.2 million |
0.00% |
1.48
|
- |
- |
-
|
CTNM Contineum Therapeutics, Inc. Class A Common Stock
|
150.1 million |
- |
-2.66
|
- |
- |
-
|
CTXR Citius Pharmaceuticals, Inc.
|
8.9 million |
0.00% |
-0.18
|
- |
- |
-
|
CUE Cue Biopharma, Inc.
|
47.0 million |
0.00% |
-1.06
|
- |
- |
-
|
CUV.AX CLINUVEL FPO [CUV]
|
337.1 million |
0.00% |
13.69
|
- |
7 |
22%
|
CVAC CureVac N.V.
|
720.5 million |
0.00% |
3.90
|
- |
- |
-
|
CVM Cel-Sci Corporation
|
17.7 million |
0.00% |
-0.44
|
- |
- |
-
|
CWBR CohBar Inc.
|
1.2 million |
0.00% |
-0.20
|
- |
- |
-
|
CYAD Celyad Oncology SA
|
16.4 million |
- |
-3.91
|
- |
- |
-
|
CYBN Cybin Inc.
|
115.9 million |
0.00% |
-1.60
|
- |
- |
-
|
CYCC Cyclacel Pharmaceuticals, Inc.
|
44.4 million |
0.00% |
-0.01
|
- |
- |
-
|
CYCCP Cyclacel Pharmaceuticals, Inc.
|
2.1 million |
6.15% |
-9.72
|
4 |
11 |
-
|
CYCN Cyclerion Therapeutics, Inc.
|
6.8 million |
0.00% |
-2.07
|
- |
- |
-
|
CYT Cyteir Therapeutics, Inc.
|
108.7 million |
0.00% |
-3.38
|
4 |
- |
-
|
CYTK Cytokinetics, Incorporated
|
4.8 billion |
0.00% |
-7.70
|
- |
- |
-
|
CYTO Altamira Therapeutics Ltd.
|
2.0 million |
0.00% |
0.28
|
- |
- |
-
|
CYTR LadRx Corporation
|
4.1 million |
- |
-2.19
|
- |
- |
-
|
CZO.V Ceapro Inc
|
16.4 million |
0.00% |
-5.83
|
- |
- |
-
|
DARE Dare Bioscience, Inc.
|
25.2 million |
0.00% |
-
|
- |
- |
-
|
DAWN Day One Biopharmaceuticals, Inc
|
731.8 million |
0.00% |
-7.08
|
- |
- |
-
|
DBTX Decibel Therapeutics, Inc.
|
84.3 million |
- |
-
|
- |
- |
-
|
DBVT DBV Technologies S.A.
|
158.0 million |
0.00% |
-1.32
|
- |
- |
-
|
DFFN Diffusion Pharmaceuticals Inc.
|
7.8 million |
- |
-2.01
|
- |
- |
-
|
DICE DICE Therapeutics, Inc.
|
1.6 billion |
- |
11.66
|
- |
- |
-
|
DMAC DiaMedica Therapeutics Inc.
|
157.7 million |
0.00% |
-6.13
|
- |
- |
-
|
DNA Ginkgo Bioworks Holdings, Inc.
|
323.2 million |
0.00% |
-0.53
|
- |
- |
-
|
DNLI Denali Therapeutics Inc.
|
1.7 billion |
0.00% |
-4.58
|
- |
- |
-
|
DOMH Dominari Holdings Inc.
|
50.8 million |
0.00% |
-0.91
|
- |
1 |
-
|
DRMA Dermata Therapeutics, Inc.
|
5.1 million |
0.00% |
-0.12
|
- |
- |
-
|
DRMAW Dermata Therapeutics, Inc. Warrant
|
82546 |
0.00% |
-0.01
|
- |
- |
-
|
DRNA Dicerna Pharmaceuticals, Inc.
|
2.9 billion |
- |
-14.22
|
- |
- |
-
|
DRUG Bright Minds Biosciences Inc.
|
233.3 million |
0.00% |
-236.57
|
- |
- |
-
|
DSGN Design Therapeutics, Inc.
|
203.2 million |
0.00% |
-4.07
|
- |
- |
-
|
DTIL Precision BioSciences, Inc.
|
48.8 million |
0.00% |
4.48
|
- |
- |
-
|
DWTX Dogwood Therapeutics, Inc.
|
8.0 million |
0.00% |
-0.66
|
- |
- |
-
|
DYAI Dyadic International, Inc.
|
40.3 million |
0.00% |
-6.70
|
- |
- |
-
|
DYN Dyne Therapeutics, Inc.
|
934.9 million |
0.00% |
-2.45
|
4 |
- |
-
|
EARS Auris Medical Holding Ltd.
|
39.2 million |
3.88% |
-0.56
|
- |
- |
-
|
EDIT Editas Medicine, Inc.
|
92.9 million |
0.00% |
-0.39
|
- |
- |
-
|
EDSA Edesa Biotech, Inc.
|
16.2 million |
0.00% |
-1.24
|
- |
- |
-
|
EFTR eFFECTOR Therapeutics, Inc.
|
941 |
0.00% |
-0.65
|
- |
- |
-
|
EFTRW eFFECTOR Therapeutics, Inc.
|
23.4 million |
0.00% |
-0.12
|
- |
- |
-
|
EIGR Eiger BioPharmaceuticals, Inc.
|
2.6 million |
0.00% |
-0.10
|
- |
- |
-
|
ELDN Eledon Pharmaceuticals, Inc.
|
188.8 million |
0.00% |
-4.21
|
- |
- |
-
|
ELEV Elevation Oncology, Inc.
|
15.3 million |
0.00% |
-0.33
|
- |
- |
-
|
ELOX Eloxx Pharmaceuticals, Inc.
|
314 |
0.00% |
-0.10
|
- |
- |
-
|
ELVN Enliven Therapeutics, Inc.
|
981.6 million |
0.00% |
-10.60
|
- |
- |
-
|
ELYM Eliem Therapeutics, Inc
|
342.7 million |
0.00% |
-1.85
|
- |
- |
-
|
EMMA Emmaus Life Sciences, Inc.
|
1.1 million |
0.00% |
-0.34
|
- |
- |
-
|
ENLV Enlivex Therapeutics Ltd.
|
20.5 million |
0.00% |
-1.27
|
- |
- |
-
|
ENOB Enochian Biosciences Inc.
|
72.4 million |
- |
-14.56
|
- |
- |
-
|
ENSC Ensysce Biosciences, Inc.
|
3.9 million |
0.00% |
-0.20
|
- |
- |
-
|
ENTA Enanta Pharmaceuticals, Inc.
|
100.9 million |
0.00% |
-0.96
|
- |
- |
-
|
ENTX Entera Bio Ltd.
|
74.5 million |
0.00% |
-6.56
|
- |
- |
-
|
ENVB Enveric Biosciences, Inc.
|
3.2 million |
0.00% |
-0.06
|
- |
- |
-
|
ENZN Enzon Pharmaceuticals, Inc.
|
7.4 million |
0.00% |
-10
|
1 |
- |
-
|
EPIX ESSA Pharma Inc.
|
65.7 million |
0.00% |
-2.14
|
- |
- |
-
|
EPZM Epizyme, Inc.
|
247.5 million |
1.66% |
-5.27
|
- |
- |
-
|
EQ Equillium, Inc.
|
16.7 million |
0.00% |
-2.04
|
- |
- |
-
|
EQRX EQRx, Inc.
|
1.2 billion |
- |
-
|
- |
- |
-
|
EQRXW EQRx, Inc.
|
- |
- |
-
|
- |
- |
-
|
ERAS Erasca, Inc.
|
328.0 million |
0.00% |
-1.68
|
- |
- |
-
|
ERYP PHAXIAM Therapeutics S.A.
|
23.9 million |
- |
-1.86
|
- |
- |
-
|
ETNB 89bio, Inc.
|
1.0 billion |
0.00% |
-1.95
|
- |
- |
-
|
ETTX Entasis Therapeutics Holdings Inc.
|
104.3 million |
- |
-0.51
|
- |
- |
-
|
EVAX Evaxion Biotech A/S
|
13.3 million |
0.00% |
-
|
- |
- |
-
|
EVFM Evofem Biosciences, Inc.
|
1.1 million |
0.00% |
-0.08
|
- |
- |
-
|
EVFMD Evofem Biosciences, Inc.
|
- |
- |
-
|
- |
- |
-
|
EVGN Evogene Ltd.
|
6.3 million |
0.00% |
-0.40
|
- |
- |
-
|
EVLO Evelo Biosciences, Inc.
|
9491 |
0.00% |
-1.81
|
- |
- |
-
|
EWTX Edgewise Therapeutics, Inc.
|
1.2 billion |
0.00% |
-7.94
|
- |
- |
-
|
EXAI Exscientia Plc
|
733.9 million |
0.00% |
-
|
- |
- |
-
|
EXEL Exelixis, Inc.
|
9.7 billion |
0.00% |
19.64
|
- |
- |
-
|
EYEG EyeGate Pharmaceuticals, Inc.
|
13.8 million |
- |
-1.72
|
- |
- |
-
|
EYEN Eyenovia, Inc.
|
3.1 million |
0.00% |
-
|
- |
- |
-
|
EYPT EyePoint Pharmaceuticals, Inc.
|
316.8 million |
0.00% |
-1.99
|
- |
- |
-
|
EZZ.AX EZZ LIFE FPO [EZZ]
|
44.0 million |
0.00% |
6.95
|
2 |
4 |
-
|
FATE Fate Therapeutics, Inc.
|
80.3 million |
0.00% |
-0.43
|
- |
- |
-
|
FBIO Fortress Biotech, Inc.
|
44.9 million |
0.00% |
-
|
- |
- |
-
|
FBIOP Fortress Biotech, Inc. - 9.375%
|
30.8 million |
42.91% |
-
|
12 |
8 |
-
|
FBRX Forte Biosciences, Inc.
|
43.3 million |
0.00% |
-0.54
|
- |
- |
-
|
FDMT 4D Molecular Therapeutics, Inc.
|
133.6 million |
0.00% |
-0.97
|
- |
- |
-
|
FENC Fennec Pharmaceuticals Inc.
|
163.9 million |
0.00% |
-297
|
- |
- |
-
|
FERMENTA.BO FERMENTA BIOTECH LIMITED
|
105.4 million |
- |
24.93
|
1 |
4 |
-
|
FGEN FibroGen, Inc
|
30.9 million |
0.00% |
-0.20
|
- |
- |
-
|
FHTX Foghorn Therapeutics Inc.
|
172.0 million |
0.00% |
-1.96
|
- |
- |
-
|
FIXX Homology Medicines, Inc.
|
51.9 million |
0.00% |
-0.31
|
- |
- |
-
|
FMTX Forma Therapeutics Holdings, Inc.
|
998.7 million |
- |
-
|
- |
- |
-
|
FNCH Finch Therapeutics Group, Inc.
|
22.2 million |
0.00% |
-1.57
|
- |
- |
-
|
FOLD Amicus Therapeutics, Inc.
|
2.4 billion |
0.00% |
-43.28
|
- |
- |
-
|
FREQ Frequency Therapeutics, Inc.
|
10.9 million |
- |
-42.89
|
- |
- |
-
|
FRLN Freeline Therapeutics Holdings plc
|
28.2 million |
0.00% |
-0.56
|
- |
- |
-
|
FSTX F-star Therapeutics, Inc.
|
156.5 million |
- |
-
|
- |
- |
-
|
FTRE Fortrea Holdings Inc.
|
677.4 million |
0.00% |
-2.48
|
- |
- |
-
|
FULC Fulcrum Therapeutics, Inc.
|
137.6 million |
0.00% |
-15.94
|
- |
- |
-
|
FUSN Fusion Pharmaceuticals Inc.
|
1.8 billion |
0.00% |
-6.94
|
- |
- |
-
|
FWBI First Wave BioPharma, Inc.
|
5.8 million |
0.00% |
0.00
|
- |
- |
-
|
FWP Forward Pharma A/S
|
20.5 million |
1393.21% |
-7.66
|
- |
- |
-
|
GALT Galectin Therapeutics Inc.
|
82.2 million |
0.00% |
-1.74
|
- |
- |
-
|
GANX Gain Therapeutics, Inc.
|
49.7 million |
0.00% |
-2.01
|
- |
- |
-
|
GBIM GlobeImmune, Inc.
|
2.0 million |
- |
-0.27
|
- |
- |
-
|
GBIO Generation Bio Co.
|
24.9 million |
0.00% |
-0.19
|
- |
- |
-
|
GBT Global Blood Therapeutics, Inc.
|
4.6 billion |
- |
-9.31
|
- |
- |
-
|
GENSF Genus plc
|
1.9 billion |
1.39% |
44.29
|
2 |
13 |
4%
|
GENSY GENUS UNSPON ADR EA REPR 1 ORD
|
1.5 billion |
- |
-
|
- |
1 |
-
|
GERN Geron Corporation
|
936.2 million |
0.00% |
-5.44
|
- |
- |
-
|
GHRS GH Research PLC
|
625.9 million |
0.00% |
-13.45
|
- |
- |
-
|
GLMD Galmed Pharmaceuticals Ltd.
|
2.2 million |
0.00% |
0.02
|
- |
- |
-
|
GLPG Galapagos NV
|
1.6 billion |
0.00% |
-1205.50
|
- |
- |
-
|
GLPG.AS GALAPAGOS
|
1.6 billion |
0.00% |
-1088
|
- |
- |
-
|
GLSI Greenwich LifeSciences, Inc.
|
121.6 million |
0.00% |
-11.42
|
- |
- |
-
|
GLTO Galecto, Inc.
|
3.4 million |
0.00% |
-0.14
|
- |
- |
-
|
GLUE Monte Rosa Therapeutics, Inc.
|
216.9 million |
- |
-1.61
|
- |
- |
-
|
GLYC GlycoMimetics, Inc.
|
11.9 million |
0.00% |
-0.31
|
- |
- |
-
|
GMAB Genmab A/S
|
11.7 billion |
0.00% |
10.51
|
- |
- |
-
|
GMDA Gamida Cell Ltd.
|
4.3 million |
0.00% |
-0.47
|
- |
- |
-
|
GMTX Gemini Therapeutics, Inc.
|
71.1 million |
- |
-
|
- |
- |
-
|
GNCA Genocea Biosciences, Inc.
|
396373 |
- |
-1.64
|
- |
- |
-
|
GNFT GENFIT S.A.
|
169.2 million |
0.00% |
8.48
|
- |
- |
-
|
GNPX Genprex, Inc.
|
3.7 million |
0.00% |
-0.04
|
- |
- |
-
|
GNS.L GENUS PLC ORD 10P
|
15.3 million |
0.02% |
-292
|
2 |
25 |
2%
|
GNTA Genenta Science S.p.A.
|
66.0 million |
0.00% |
-6.81
|
- |
- |
-
|
GOSS Gossamer Bio, Inc.
|
213.8 million |
0.00% |
-3.76
|
- |
- |
-
|
GOVX GeoVax Labs, Inc.
|
14.9 million |
0.00% |
-0.22
|
- |
- |
-
|
GOVXW GeoVax Labs, Inc.
|
15.2 million |
0.00% |
-
|
- |
- |
-
|
GRAY Graybug Vision, Inc.
|
121.0 million |
- |
-
|
- |
- |
-
|
GRCL Gracell Biotechnologies Inc.
|
989.9 million |
0.00% |
-10.59
|
- |
- |
-
|
GRI GRI Bio, Inc.
|
877348 |
0.00% |
-0.03
|
4 |
- |
-
|
GRPH Graphite Bio, Inc.
|
189.8 million |
0.00% |
-1.37
|
- |
1 |
-
|
GRTS Gritstone bio, Inc.
|
3.8 million |
0.00% |
-
|
- |
- |
-
|
GRTX Galera Therapeutics, Inc.
|
2.1 million |
0.00% |
-0.09
|
- |
- |
-
|
GTBP GT Biopharma, Inc.
|
5.9 million |
0.00% |
-0.34
|
- |
- |
-
|
GTHX G1 Therapeutics, Inc.
|
377.2 million |
0.00% |
-
|
- |
- |
-
|
HALO Halozyme Therapeutics, Inc.
|
7.6 billion |
0.00% |
18.05
|
- |
- |
-
|
HARP Harpoon Therapeutics, Inc.
|
492.3 million |
0.00% |
-14.67
|
- |
- |
-
|
HCWB HCW Biologics Inc.
|
11.9 million |
0.00% |
-
|
- |
- |
-
|
HEPA Hepion Pharmaceuticals, Inc.
|
496908 |
0.00% |
-0.02
|
- |
- |
-
|
HGEN Humanigen, Inc.
|
23816 |
- |
-5.60
|
- |
- |
-
|
HILS Hillstream BioPharma, Inc.
|
4.9 million |
- |
-
|
- |
- |
-
|
HOOK HOOKIPA Pharma Inc.
|
10.5 million |
0.00% |
-0.25
|
- |
- |
-
|
HOTH Hoth Therapeutics, Inc.
|
12.9 million |
0.00% |
-0.77
|
- |
- |
-
|
HRMY Harmony Biosciences Holdings, I
|
1.8 billion |
0.00% |
12.34
|
- |
- |
-
|
HRTX Heron Therapeutics, Inc.
|
319.9 million |
0.00% |
-23.33
|
- |
- |
-
|
HSTO Histogen Inc.
|
897069 |
0.00% |
-0.12
|
- |
- |
-
|
HTBX Heat Biologics, Inc.
|
81.8 million |
4.65% |
-3.29
|
- |
- |
-
|
HUMA Humacyte, Inc.
|
226.5 million |
0.00% |
-
|
- |
- |
-
|
HUMAW Humacyte, Inc.
|
49.6 million |
0.00% |
-0.10
|
- |
- |
-
|
HURA TuHURA Biosciences, Inc.
|
147.6 million |
0.00% |
-2.79
|
- |
- |
-
|
HVO.L HVIVO PLC ORD 0.1P
|
1.3 million |
0.00% |
4.83
|
- |
3 |
-
|
IBIO iBio, Inc.
|
31.8 million |
0.00% |
2.48
|
- |
- |
-
|
IBRX ImmunityBio, Inc.
|
2.5 billion |
0.00% |
-4.79
|
- |
- |
-
|
IBT.L INTERNATIONAL BIOTECHNOLOGY TRU
|
2.5 million |
0.04% |
5.24
|
2 |
8 |
6%
|
ICCC ImmuCell Corporation
|
48.7 million |
0.00% |
-20.85
|
- |
- |
-
|
ICPT Intercept Pharmaceuticals, Inc.
|
794.7 million |
- |
-5.82
|
- |
- |
-
|
IDRA Idera Pharmaceuticals, Inc.
|
18.7 million |
- |
-0.31
|
- |
- |
-
|
IDYA IDEAYA Biosciences, Inc.
|
1.4 billion |
0.00% |
-4.63
|
- |
- |
-
|
IFRX InflaRx N.V.
|
67.8 million |
0.00% |
-1.19
|
- |
- |
-
|
IGC IGC Pharma, Inc.
|
21.5 million |
0.00% |
-2.25
|
- |
- |
-
|
IGMS IGM Biosciences, Inc.
|
67.8 million |
0.00% |
-0.35
|
- |
- |
-
|
IKNA Ikena Oncology, Inc.
|
45.5 million |
0.00% |
-1.11
|
- |
- |
-
|
IKT Inhibikase Therapeutics, Inc.
|
146.8 million |
0.00% |
-1.70
|
- |
- |
-
|
IMAB I-MAB
|
56.1 million |
0.00% |
-
|
- |
- |
-
|
IMCR Immunocore Holdings plc
|
1.5 billion |
0.00% |
-28.60
|
- |
- |
-
|
IMGN ImmunoGen, Inc.
|
8.7 billion |
0.00% |
-111.54
|
- |
- |
-
|
IMGO Imago BioSciences, Inc.
|
1.2 billion |
- |
-
|
- |
- |
-
|
IMMP Immutep Limited
|
218.3 million |
0.00% |
-7.14
|
- |
- |
-
|
IMMX Immix Biopharma, Inc.
|
43.8 million |
0.00% |
-2.08
|
- |
- |
-
|
IMNM Immunome, Inc.
|
515.6 million |
0.00% |
-1.19
|
- |
- |
-
|
IMPL Impel Pharmaceuticals Inc.
|
8.8 million |
- |
-
|
- |
- |
-
|
IMRA IMARA Inc.
|
165.8 million |
- |
105.33
|
- |
- |
-
|
IMRN Immuron Limited
|
10.2 million |
0.00% |
-2.20
|
- |
- |
-
|
IMTX Immatics N.V.
|
458.3 million |
0.00% |
25.60
|
- |
- |
-
|
IMTXW Immatics N.V.
|
484.4 million |
0.00% |
-
|
- |
- |
-
|
IMU.AX IMUGENE FPO [IMU]
|
124.0 million |
0.00% |
-1.30
|
- |
- |
-
|
IMUX Immunic, Inc.
|
89.7 million |
0.00% |
-0.99
|
- |
- |
-
|
IMV IMV Inc.
|
9.7 million |
- |
-7.90
|
- |
- |
-
|
IMVT Immunovant, Inc.
|
2.4 billion |
0.00% |
-5.46
|
- |
- |
-
|
INBX Inhibrx Biosciences, Inc.
|
196.7 million |
0.00% |
0.12
|
- |
- |
-
|
INCY Incyte Corporation
|
12.1 billion |
0.00% |
416.40
|
- |
- |
-
|
INDP Indaptus Therapeutics, Inc.
|
6.8 million |
0.00% |
-0.29
|
- |
- |
-
|
INFI I:SPX Oct 2023 Weekly 3100.000
|
17.9 million |
- |
-4.52
|
- |
- |
-
|
INKT MiNK Therapeutics, Inc.
|
33.4 million |
0.00% |
-2.94
|
- |
- |
-
|
INM InMed Pharmaceuticals Inc.
|
2.5 million |
0.00% |
-0.17
|
- |
- |
-
|
INMB INmune Bio Inc.
|
178.2 million |
0.00% |
-3.68
|
- |
- |
-
|
INO Inovio Pharmaceuticals, Inc.
|
58.3 million |
0.00% |
-0.40
|
- |
- |
-
|
INSM Insmed Incorporated
|
13.1 billion |
0.00% |
-12.99
|
- |
- |
-
|
INVA Innoviva, Inc.
|
1.1 billion |
0.00% |
49.22
|
3 |
- |
-
|
INZY Inozyme Pharma, Inc.
|
52.8 million |
0.00% |
-0.51
|
- |
- |
-
|
IOBT IO Biotech, Inc.
|
66.2 million |
0.00% |
-0.69
|
- |
- |
-
|
IONS Ionis Pharmaceuticals, Inc.
|
4.5 billion |
0.00% |
-9.38
|
- |
- |
-
|
IOVA Iovance Biotherapeutics, Inc.
|
1.1 billion |
0.00% |
-2.57
|
- |
- |
-
|
IPA ImmunoPrecise Antibodies Ltd.
|
16.5 million |
0.00% |
-0.30
|
- |
- |
-
|
IP.BK IP_INTER PHARMA
|
63.2 million |
0.00% |
58
|
1 |
2 |
-
|
IPHA Innate Pharma S.A.
|
153.4 million |
0.00% |
-2.77
|
- |
- |
-
|
IPSC Century Therapeutics, Inc.
|
39.5 million |
0.00% |
-0.29
|
- |
- |
-
|
ISEE IVERIC bio, Inc.
|
5.5 billion |
- |
-4.87
|
- |
- |
-
|
ITECH.ST I-Tech AB
|
104.7 million |
0.02% |
25.64
|
- |
2 |
-
|
ITOS iTeos Therapeutics, Inc.
|
217.7 million |
0.00% |
-1.72
|
- |
- |
-
|
ITRM Iterum Therapeutics plc
|
40.5 million |
0.00% |
-0.93
|
- |
- |
-
|
IVA Inventiva S.A. - American Depos
|
162.3 million |
0.00% |
-1.39
|
- |
- |
-
|
IXC.AX INVEX THER FPO [IXC]
|
3.1 million |
0.00% |
-3.25
|
- |
- |
-
|
JAGX Jaguar Health, Inc.
|
2.9 million |
0.00% |
-
|
- |
- |
-
|
JANX Janux Therapeutics, Inc.
|
1.6 billion |
0.00% |
-21.09
|
- |
- |
-
|
JAZZ Jazz Pharmaceuticals plc
|
7.3 billion |
0.00% |
13.97
|
- |
- |
-
|
JNCE Jounce Therapeutics, Inc.
|
101.6 million |
- |
-2.45
|
- |
- |
-
|
JUNS Jupiter Neurosciences, Inc. Common Stock
|
19.4 million |
- |
-7.34
|
- |
- |
-
|
KALA KALA BIO, Inc.
|
27.4 million |
0.00% |
-0.42
|
- |
- |
-
|
KALV KalVista Pharmaceuticals, Inc.
|
532.5 million |
0.00% |
-2.84
|
- |
- |
-
|
KDMN Kadmon Holdings, Inc.
|
1.6 billion |
- |
-13.43
|
- |
- |
-
|
KDNY Chinook Therapeutics, Inc.
|
1.5 billion |
- |
-2.01
|
- |
- |
-
|
KLDO Kaleido Biosciences, Inc.
|
4262 |
- |
-
|
- |
- |
-
|
KMPH KemPharm, Inc.
|
200.5 million |
- |
17.60
|
- |
- |
-
|
KNTE Kinnate Biopharma Inc.
|
125.0 million |
0.00% |
-0.84
|
- |
- |
-
|
KOD Kodiak Sciences Inc
|
124.0 million |
0.00% |
-0.70
|
- |
- |
-
|
KPRX Kiora Pharmaceuticals, Inc.
|
7.9 million |
0.00% |
3.02
|
- |
- |
-
|
KPTI Karyopharm Therapeutics Inc.
|
32.5 million |
0.00% |
-0.28
|
- |
- |
-
|
KRBP Kiromic BioPharma, Inc.
|
318418 |
0.00% |
-0.04
|
- |
- |
-
|
KRON Kronos Bio, Inc.
|
48.8 million |
0.00% |
-0.56
|
- |
- |
-
|
KROS Keros Therapeutics, Inc.
|
401.6 million |
0.00% |
-1.98
|
- |
- |
-
|
KRTX Karuna Therapeutics, Inc.
|
12.6 billion |
0.00% |
-29.07
|
- |
- |
-
|
KRYS Krystal Biotech, Inc.
|
5.1 billion |
0.00% |
59.38
|
- |
- |
-
|
KTRA Kintara Therapeutics, Inc.
|
10.5 million |
0.00% |
-0.01
|
- |
- |
-
|
KTTA Pasithea Therapeutics Corp.
|
3.4 million |
0.00% |
-0.10
|
- |
- |
-
|
KTTAW Pasithea Therapeutics Corp. Warrant
|
25329 |
0.00% |
-
|
- |
- |
-
|
KURA Kura Oncology, Inc.
|
526.5 million |
0.00% |
-3.23
|
- |
- |
-
|
KYMR Kymera Therapeutics, Inc.
|
1.5 billion |
0.00% |
-7.95
|
- |
- |
-
|
KZIA Kazia Therapeutics Limited
|
2.6 million |
0.00% |
-0.12
|
- |
- |
-
|
KZR Kezar Life Sciences, Inc.
|
30.1 million |
0.00% |
-0.36
|
- |
- |
-
|
LABP Landos Biopharma, Inc.
|
69.4 million |
0.00% |
-1.37
|
- |
- |
-
|
LBPH Longboard Pharmaceuticals, Inc.
|
2.3 billion |
0.00% |
-8.09
|
- |
- |
-
|
LBPS 4D pharma plc
|
37.2 million |
- |
-
|
- |
- |
-
|
LCTX Lineage Cell Therapeutics, Inc.
|
95.3 million |
0.00% |
-4.64
|
- |
- |
-
|
LEGN Legend Biotech Corporation
|
3.0 billion |
0.00% |
-34.31
|
- |
- |
-
|
LENZ LENZ Therapeutics, Inc.
|
633.5 million |
0.00% |
-9.83
|
- |
1 |
-
|
LEXX Lexaria Bioscience Corp.
|
24.4 million |
0.00% |
-
|
- |
- |
-
|
LGND Ligand Pharmaceuticals Incorpor
|
2.1 billion |
0.00% |
-494.23
|
- |
- |
-
|
LIAN LianBio
|
34.5 million |
0.00% |
-4.99
|
- |
1 |
-
|
LIFE aTyr Pharma, Inc.
|
131.1 million |
0.00% |
-1.77
|
- |
- |
-
|
LIXT Lixte Biotechnology Holdings, I
|
3.2 million |
0.00% |
-0.75
|
- |
- |
-
|
LIXTW Lixte Biotechnology Holdings, I
|
71534 |
0.00% |
-
|
- |
- |
-
|
LJPC La Jolla Pharmaceutical Company
|
171.2 million |
0.00% |
38.78
|
- |
- |
-
|
LMNL Liminal BioSciences Inc.
|
21.0 million |
- |
0.71
|
- |
- |
-
|
LOGC LogicBio Therapeutics, Inc.
|
68.2 million |
- |
-3.94
|
- |
- |
-
|
LPCN Lipocine Inc.
|
17.0 million |
0.00% |
-4.23
|
- |
- |
-
|
LPTX Leap Therapeutics, Inc.
|
12.9 million |
0.00% |
-0.17
|
- |
- |
-
|
LQDA Liquidia Corporation
|
1.1 billion |
0.00% |
-7.77
|
- |
- |
-
|
LRMR Larimar Therapeutics, Inc.
|
126.8 million |
0.00% |
-1.50
|
- |
- |
-
|
LTRN Lantern Pharma Inc.
|
32.2 million |
0.00% |
-1.55
|
- |
- |
-
|
LUMO Lumos Pharma, Inc.
|
37.5 million |
0.00% |
-
|
- |
- |
-
|
LVTX LAVA Therapeutics N.V.
|
30.5 million |
0.00% |
-1.23
|
- |
- |
-
|
LXRX Lexicon Pharmaceuticals, Inc.
|
151.4 million |
0.00% |
-0.66
|
- |
- |
-
|
LYEL Lyell Immunopharma, Inc.
|
137.3 million |
0.00% |
-0.35
|
- |
- |
-
|
LYRA Lyra Therapeutics, Inc.
|
7.4 million |
0.00% |
-0.08
|
- |
- |
-
|
MACK Merrimack Pharmaceuticals, Inc.
|
218.4 million |
0.00% |
-138
|
- |
- |
-
|
MAGLE.ST Magle Chemoswed Holding AB
|
57.6 million |
0.01% |
17.20
|
- |
1 |
-
|
MAIA MAIA Biotechnology, Inc.
|
44.4 million |
0.00% |
-1.43
|
- |
- |
-
|
MAZE Maze Therapeutics, Inc.
|
413.9 million |
0.00% |
118.19
|
- |
- |
-
|
MBIO Mustang Bio, Inc.
|
4.3 million |
0.00% |
-0.02
|
- |
- |
-
|
MBRX Moleculin Biotech, Inc.
|
12.2 million |
0.00% |
-0.14
|
- |
- |
-
|
MBX MBX Biosciences, Inc. Common Stock
|
201.9 million |
0.00% |
-1.04
|
- |
- |
-
|
MCRB Seres Therapeutics, Inc.
|
119.9 million |
0.00% |
-0.85
|
- |
- |
-
|
MDGL Madrigal Pharmaceuticals, Inc.
|
7.2 billion |
0.00% |
-14.94
|
- |
- |
-
|
MDNA Medicenna Therapeutics Corp.
|
11.2 million |
- |
-18.44
|
- |
- |
-
|
MDWD MediWound Ltd.
|
180.0 million |
0.00% |
-5.28
|
- |
- |
-
|
MDXG MiMedx Group, Inc
|
1.1 billion |
0.00% |
26.23
|
- |
- |
-
|
MEIP MEI Pharma, Inc.
|
14.2 million |
0.00% |
-0.37
|
- |
- |
-
|
MESO Mesoblast Limited
|
1.3 billion |
0.00% |
-11.24
|
- |
- |
-
|
MGNX MacroGenics, Inc.
|
72.6 million |
0.00% |
-1.07
|
- |
- |
-
|
MGTA Magenta Therapeutics, Inc. Common Stock
|
44.2 million |
- |
-3.45
|
- |
- |
-
|
MGTX MeiraGTx Holdings plc
|
453.8 million |
0.00% |
-2.71
|
- |
- |
-
|
MIRM Mirum Pharmaceuticals, Inc.
|
2.2 billion |
0.00% |
-24.32
|
- |
- |
-
|
MIRO Miromatrix Medical Inc.
|
93.0 million |
- |
-
|
- |
- |
-
|
MIST Milestone Pharmaceuticals Inc.
|
40.0 million |
0.00% |
-1.12
|
- |
- |
-
|
MITO Stealth BioTherapeutics Corp
|
18.4 million |
- |
-2.07
|
- |
- |
-
|
MLND Millendo Therapeutics, Inc.
|
20.2 million |
- |
-0.64
|
- |
- |
-
|
MNKD MannKind Corporation
|
1.5 billion |
0.00% |
50.20
|
- |
- |
-
|
MNMD Mind Medicine (MindMed) Inc.
|
409.3 million |
0.00% |
-3.53
|
- |
- |
-
|
MNOV MediciNova, Inc.
|
65.7 million |
0.00% |
-5.83
|
- |
- |
-
|
MNPR Monopar Therapeutics Inc.
|
183.4 million |
0.00% |
-7.30
|
- |
- |
-
|
MOLN Molecular Partners AG
|
137.2 million |
0.00% |
-2.07
|
- |
- |
-
|
MOR MorphoSys AG
|
2.9 billion |
0.00% |
-
|
- |
- |
-
|
MORF Morphic Holding, Inc.
|
2.9 billion |
0.00% |
-10.56
|
- |
- |
-
|
MREO Mereo BioPharma Group plc
|
308.7 million |
0.00% |
-6.63
|
- |
- |
-
|
MRKR Marker Therapeutics, Inc.
|
10.7 million |
0.00% |
-
|
- |
- |
-
|
MRNA Moderna, Inc.
|
10.7 billion |
0.00% |
-2.99
|
- |
- |
-
|
MRNS Marinus Pharmaceuticals, Inc.
|
30.4 million |
0.00% |
-
|
- |
- |
-
|
MRSN Mersana Therapeutics, Inc.
|
37.8 million |
0.00% |
-0.54
|
- |
- |
-
|
MRTX Mirati Therapeutics, Inc.
|
4.2 billion |
- |
-4.71
|
- |
- |
-
|
MRUS Merus N.V.
|
2.6 billion |
0.00% |
-11.28
|
- |
- |
-
|
MRVI Maravai LifeSciences Holdings,
|
301.7 million |
0.00% |
-2
|
- |
- |
-
|
MTCR Metacrine, Inc.
|
25.5 million |
- |
-
|
- |
1 |
-
|
MTEM Molecular Templates, Inc.
|
1317 |
0.00% |
-
|
- |
- |
-
|
MTNB Matinas Biopharma Holdings, Inc
|
2.7 million |
0.00% |
-0.11
|
- |
- |
-
|
MTP Midatech Pharma PLC
|
2.0 million |
0.00% |
-0.34
|
- |
- |
-
|
MTSR Metsera, Inc.
|
2.2 billion |
0.00% |
-
|
- |
- |
-
|
MYMD MyMD Pharmaceuticals, Inc.
|
4.5 million |
0.00% |
-0.82
|
- |
- |
-
|
MYMX Mymetics Corporation
|
334134 |
0.34% |
-0.02
|
- |
- |
-
|
MYOV Myovant Sciences Ltd.
|
2.6 billion |
- |
-7.04
|
- |
- |
-
|
NAUT Nautilus Biotechnology, Inc.
|
112.5 million |
0.00% |
-1.59
|
- |
- |
-
|
NAVB Navidea Biopharmaceuticals, Inc
|
3.5 million |
0.00% |
-0.17
|
- |
- |
-
|
NBRV Nabriva Therapeutics plc
|
6.0 million |
- |
-0.62
|
- |
- |
-
|
NBSE NeuBase Therapeutics, Inc.
|
1.4 million |
0.00% |
-0.04
|
- |
- |
-
|
NBTX Nanobiotix S.A.
|
158.6 million |
0.00% |
-
|
- |
- |
-
|
NBY NovaBay Pharmaceuticals, Inc.
|
3.4 million |
0.00% |
-
|
- |
- |
-
|
NCNA NuCana plc
|
4.5 million |
0.00% |
-0.09
|
- |
- |
-
|
NERV Minerva Neurosciences, Inc
|
10.8 million |
0.00% |
8.11
|
- |
- |
-
|
NEXI NexImmune, Inc.
|
139 |
0.00% |
-0.01
|
- |
- |
-
|
NGEN.V NERVGEN PHARMA CORP
|
169.1 million |
0.00% |
-8.68
|
- |
- |
-
|
NGM NGM Biopharmaceuticals, Inc.
|
128.5 million |
0.00% |
-0.83
|
- |
- |
-
|
NK NantKwest, Inc.
|
3.6 billion |
- |
-10.73
|
- |
- |
-
|
NKTR Nektar Therapeutics
|
122.6 million |
0.00% |
-1.14
|
- |
- |
-
|
NKTX Nkarta, Inc.
|
121.0 million |
0.00% |
-1.07
|
- |
- |
-
|
NLTX Neoleukin Therapeutics, Inc.
|
31.5 million |
- |
-19.78
|
- |
- |
-
|
NMTR 9 Meters Biopharma, Inc.
|
11.1 million |
- |
-0.88
|
- |
- |
-
|
NNVC NanoViricides, Inc.
|
16.9 million |
0.00% |
-1.52
|
- |
- |
-
|
NOVC.DE Novo Nordisk A/S
|
398.4 billion |
1.06% |
22.93
|
1 |
22 |
12%
|
NOVN Novan, Inc.
|
33.9 million |
- |
-2.25
|
- |
- |
-
|
NOVNQ NVN Liquidation, Inc.
|
2802 |
- |
-
|
- |
- |
-
|
NRBO NeuroBo Pharmaceuticals, Inc.
|
21.6 million |
0.00% |
13.28
|
- |
- |
-
|
NRIX Nurix Therapeutics, Inc.
|
748.6 million |
0.00% |
-
|
- |
- |
-
|
NRSN NeuroSense Therapeutics Ltd.
|
21.6 million |
0.00% |
-1.22
|
- |
- |
-
|
NRSNW NEUROSENSE THERAPEUTICS LTD C/W
|
21.3 million |
0.00% |
-0.22
|
- |
- |
-
|
NRXP NRX Pharmaceuticals, Inc.
|
31.6 million |
0.00% |
-0.79
|
- |
- |
-
|
NRXPW NRx Pharmaceuticals, Inc.
|
1.2 million |
0.00% |
-0.01
|
- |
- |
-
|
NTEC Intec Pharma Ltd
|
46.4 million |
- |
-0.47
|
- |
- |
-
|
NTII Neurobiological Technologies, Inc.
|
10862 |
1.06% |
-
|
1 |
- |
-
|
NTLA Intellia Therapeutics, Inc.
|
713.2 million |
0.00% |
-1.31
|
- |
- |
-
|
NTRB Nutriband Inc.
|
61.1 million |
0.00% |
-7.75
|
- |
- |
-
|
NTRBW Nutriband Inc. Warrant
|
77.2 million |
0.00% |
-2.51
|
- |
- |
-
|
NVAX Novavax, Inc.
|
966.7 million |
0.00% |
-4.89
|
- |
- |
-
|
NVIV InVivo Therapeutics Holdings Corp.
|
995917 |
0.00% |
-0.16
|
- |
- |
-
|
NWBO Northwest Biotherapeutics, Inc.
|
292.1 million |
0.00% |
-3.50
|
- |
- |
-
|
NXTC NextCure, Inc.
|
11.0 million |
0.00% |
-0.20
|
- |
- |
-
|
NYMX Nymox Pharmaceutical Corporation
|
43.0 million |
- |
-10.83
|
- |
- |
-
|
OBSV ObsEva SA
|
11.0 million |
- |
-1.14
|
- |
- |
-
|
OCEA Ocean Biomedical, Inc.
|
6.7 million |
0.00% |
-0.05
|
- |
- |
-
|
OCGN Ocugen, Inc.
|
193.3 million |
0.00% |
-3.31
|
- |
- |
-
|
OCS Oculis Holding AG
|
744.0 million |
0.00% |
-6.46
|
- |
- |
-
|
OCUL Ocular Therapeutix, Inc.
|
1.0 billion |
0.00% |
-5.21
|
- |
- |
-
|
OCUP Ocuphire Pharma, Inc.
|
31.7 million |
0.00% |
-
|
- |
- |
-
|
ODT Odonate Therapeutics, Inc.
|
51.0 million |
- |
-3.67
|
- |
- |
-
|
OGEN Oragenics Inc.
|
4.0 million |
0.00% |
-0.12
|
- |
- |
-
|
OKYO OKYO Pharma Limited
|
38.6 million |
0.00% |
-3
|
- |
- |
-
|
OLMA Olema Pharmaceuticals, Inc.
|
223.4 million |
0.00% |
-1.49
|
- |
- |
-
|
OMER Omeros Corporation
|
427.4 million |
0.00% |
-2.34
|
- |
- |
-
|
OMGA Omega Therapeutics, Inc.
|
10.4 million |
0.00% |
-0.14
|
- |
- |
-
|
ONCR Oncorus, Inc.
|
547992 |
- |
-
|
- |
- |
-
|
ONCS OncoSec Medical Incorporated
|
3.8 million |
- |
-1.88
|
- |
- |
-
|
ONCT Oncternal Therapeutics, Inc.
|
1.6 million |
0.00% |
-
|
- |
- |
-
|
ONCY Oncolytics Biotech Inc.
|
44.2 million |
0.00% |
-1.83
|
- |
- |
-
|
ONT.L OXFORD NANOPORE TECHNOLOGIES PL
|
13.8 million |
0.00% |
-6.80
|
- |
- |
-
|
ONTX Onconova Therapeutics, Inc.
|
17.6 million |
0.00% |
-0.68
|
- |
- |
-
|
ONVO Organovo Holdings, Inc.
|
3.7 million |
0.00% |
-0.22
|
- |
- |
-
|
OPNT Opiant Pharmaceuticals, Inc.
|
108.8 million |
- |
34.80
|
- |
- |
-
|
OPORF HVIVO PLC
|
251.6 million |
0.01% |
-
|
- |
- |
-
|
OPT Opthea Limited
|
65.6 million |
0.00% |
-1.52
|
- |
- |
-
|
ORGS Orgenesis, Inc.
|
12.9 million |
0.00% |
-0.10
|
- |
- |
-
|
ORIC Oric Pharmaceuticals, Inc.
|
346.6 million |
0.00% |
-2.67
|
- |
- |
-
|
ORMP Oramed Pharmaceuticals Inc.
|
88.2 million |
0.00% |
-4.50
|
- |
- |
-
|
ORPH Orphazyme A/S
|
86.0 million |
- |
-3.59
|
- |
- |
-
|
ORTX Orchard Therapeutics plc
|
753.2 million |
- |
-4.05
|
- |
- |
-
|
OSMT Osmotica Pharmaceuticals plc
|
65.9 million |
- |
-6.37
|
- |
- |
-
|
OTIC Otonomy, Inc.
|
582482 |
- |
-3.12
|
- |
- |
-
|
OTLK Outlook Therapeutics, Inc.
|
38.4 million |
0.00% |
-0.48
|
- |
- |
-
|
OVID Ovid Therapeutics Inc.
|
24.2 million |
0.00% |
-0.92
|
- |
- |
-
|
OYST Oyster Point Pharma, Inc.
|
298.5 million |
- |
-8.09
|
- |
- |
-
|
PALI Palisade Bio, Inc.
|
2.8 million |
0.00% |
-0.06
|
- |
- |
-
|
PASG Passage Bio, Inc.
|
21.1 million |
0.00% |
-0.32
|
- |
- |
-
|
PBLA Panbela Therapeutics, Inc.
|
1.6 million |
0.00% |
-0.01
|
- |
- |
-
|
PBYI Puma Biotechnology Inc
|
142.9 million |
0.00% |
4.65
|
- |
- |
-
|
PCSA Processa Pharmaceuticals, Inc.
|
1.6 million |
0.00% |
-0.08
|
- |
- |
-
|
PCVX Vaxcyte, Inc.
|
4.1 billion |
0.00% |
-8.32
|
- |
- |
-
|
PDSB PDS Biotechnology Corporation
|
48.6 million |
0.00% |
-1.04
|
- |
- |
-
|
PGEN Precigen, Inc.
|
364.6 million |
0.00% |
-2.64
|
- |
- |
-
|
PHAR Pharming Group N.V.
|
521.7 million |
0.00% |
-48.06
|
1 |
- |
-
|
PHARM.AS PHARMING GROUP
|
554.3 million |
0.00% |
-71.65
|
- |
- |
-
|
PHAS PhaseBio Pharmaceuticals, Inc.
|
3.4 million |
- |
-1.33
|
- |
- |
-
|
PHAT Phathom Pharmaceuticals, Inc.
|
339.8 million |
0.00% |
-0.92
|
- |
- |
-
|
PHGE BiomX Inc.
|
14.5 million |
0.00% |
-0.39
|
- |
- |
-
|
PHGUF Pharming Group N.V.
|
769.8 million |
- |
-38.33
|
- |
- |
-
|
PHIO Phio Pharmaceuticals Corp.
|
5.5 million |
0.00% |
-0.12
|
- |
- |
-
|
PHIOW Phio Pharmaceuticals Corp.
|
421414 |
- |
-
|
- |
- |
-
|
PHM.MC PHARMA MAR, S.A.
|
1.6 billion |
0.81% |
52.25
|
1 |
5 |
-
|
PHMMF PHARMA MAR SA
|
628.5 million |
0.02% |
-
|
- |
- |
-
|
PHR.WA PHARMENA
|
12.9 million |
0.00% |
145
|
1 |
1 |
-
|
PHVS Pharvaris N.V.
|
789.6 million |
0.00% |
-5.20
|
- |
- |
-
|
PIRS Pieris Pharmaceuticals, Inc.
|
21.9 million |
0.00% |
-
|
- |
- |
-
|
PLRX Pliant Therapeutics, Inc.
|
80.2 million |
0.00% |
-0.38
|
- |
- |
-
|
PLX Protalix BioTherapeutics, Inc.
|
186.5 million |
0.00% |
59.75
|
- |
- |
-
|
PMCB PharmaCyte Biotech, Inc.
|
8.5 million |
0.00% |
0.93
|
- |
- |
-
|
PMVP PMV Pharmaceuticals, Inc.
|
51.9 million |
0.00% |
-0.88
|
- |
- |
-
|
PNT POINT Biopharma Global Inc.
|
1.5 billion |
- |
12.51
|
- |
- |
-
|
PPBT Purple Biotech Ltd.
|
34960 |
0.00% |
-0.05
|
- |
- |
-
|
PRAX Praxis Precision Medicines, Inc
|
679.1 million |
0.00% |
-3.30
|
- |
- |
-
|
PRDS Pardes Biosciences, Inc.
|
116.3 million |
- |
-
|
- |
- |
-
|
PRLD Prelude Therapeutics Incorporat
|
39.1 million |
0.00% |
-0.42
|
- |
- |
-
|
PROG Progenity, Inc.
|
340.6 million |
- |
-0.48
|
- |
- |
-
|
PRQR ProQR Therapeutics N.V.
|
124.2 million |
0.00% |
-3.37
|
- |
- |
-
|
PRTA Prothena Corporation plc
|
609.3 million |
0.00% |
-4.99
|
- |
- |
-
|
PRTC PureTech Health plc
|
457.8 million |
0.00% |
-6.35
|
- |
- |
-
|
PRTG Portage Biotech Inc.
|
6.2 million |
0.00% |
-0.08
|
- |
- |
-
|
PRTK Paratek Pharmaceuticals, Inc.
|
106.0 million |
0.00% |
-4.84
|
- |
- |
-
|
PRVB Provention Bio, Inc.
|
2.3 billion |
- |
-9.92
|
- |
- |
-
|
PSTI Pluristem Therapeutics Inc.
|
32.1 million |
- |
-6.23
|
- |
- |
-
|
PSTV PLUS THERAPEUTICS, Inc.
|
13.2 million |
0.00% |
-0.33
|
- |
- |
-
|
PSTX Poseida Therapeutics, Inc.
|
927.9 million |
0.00% |
-
|
- |
- |
-
|
PTCT PTC Therapeutics, Inc.
|
3.4 billion |
0.00% |
-9.14
|
- |
- |
-
|
PTE PolarityTE, Inc.
|
3.3 million |
- |
-0.56
|
- |
- |
-
|
PTGX Protagonist Therapeutics, Inc.
|
2.7 billion |
0.00% |
10.51
|
- |
- |
-
|
PTIX Protagenic Therapeutics, Inc.
|
3.1 million |
0.00% |
-0.33
|
- |
- |
-
|
PTIXW Protagenic Therapeutics, Inc. Warrant
|
3.7 million |
0.00% |
-
|
- |
- |
-
|
PTN Palatin Technologies, Inc.
|
14.0 million |
0.00% |
-0.35
|
- |
- |
-
|
PULM Pulmatrix, Inc.
|
19.5 million |
0.00% |
-2.04
|
- |
- |
-
|
PYPD PolyPid Ltd.
|
26.6 million |
0.00% |
-0.53
|
- |
- |
-
|
PYXS Pyxis Oncology, Inc.
|
60.7 million |
0.00% |
-0.77
|
- |
- |
-
|
QLGN Qualigen Therapeutics, Inc.
|
2.4 million |
0.00% |
0.00
|
- |
- |
-
|
QNRX Quoin Pharmaceuticals, Ltd.
|
2.3 million |
0.00% |
-0.14
|
- |
- |
-
|
QURE uniQure N.V.
|
521.0 million |
0.00% |
-1.96
|
- |
- |
-
|
RAIN Rain Oncology Inc.
|
43.7 million |
- |
-
|
- |
- |
-
|
RAPT RAPT Therapeutics, Inc.
|
149.2 million |
0.00% |
-0.35
|
- |
- |
-
|
RARE Ultragenyx Pharmaceutical Inc.
|
3.0 billion |
0.00% |
-5.16
|
- |
- |
-
|
RCKT Rocket Pharmaceuticals, Inc.
|
671.8 million |
0.00% |
-2.31
|
- |
- |
-
|
RCOR Renovacor, Inc.
|
51.2 million |
- |
-
|
- |
- |
-
|
RCUS Arcus Biosciences, Inc.
|
727.1 million |
0.00% |
-2.19
|
- |
- |
-
|
REGN Regeneron Pharmaceuticals, Inc.
|
61.7 billion |
0.00% |
14.95
|
- |
1 |
-
|
REPL Replimune Group, Inc.
|
607.6 million |
0.00% |
-2.57
|
- |
- |
-
|
RETA Reata Pharmaceuticals, Inc.
|
3.9 billion |
- |
-13.24
|
- |
- |
-
|
REVB Revelation Biosciences, Inc.
|
2.4 million |
0.00% |
-0.03
|
- |
- |
-
|
REVBU Revelation Biosciences, Inc.
|
- |
- |
-
|
- |
- |
-
|
REVBW Revelation Biosciences, Inc.
|
12673 |
0.00% |
-
|
- |
- |
-
|
RGLS Regulus Therapeutics Inc.
|
119.2 million |
0.00% |
-2.20
|
- |
- |
-
|
RGNX REGENXBIO Inc.
|
334.1 million |
0.00% |
-1.45
|
- |
- |
-
|
RIGL Rigel Pharmaceuticals, Inc.
|
301.0 million |
0.00% |
17.02
|
- |
- |
-
|
RLAY Relay Therapeutics, Inc.
|
388.2 million |
0.00% |
-0.97
|
- |
- |
-
|
RLMD Relmada Therapeutics, Inc.
|
9.2 million |
0.00% |
-0.10
|
- |
- |
-
|
RNA Avidity Biosciences, Inc.
|
3.3 billion |
0.00% |
-9.55
|
- |
- |
-
|
RNXT RenovoRx, Inc.
|
35.6 million |
0.00% |
-1.72
|
- |
- |
-
|
ROIV Roivant Sciences Ltd.
|
6.8 billion |
0.00% |
-9.46
|
- |
- |
-
|
ROIVW Roivant Sciences Ltd. Warrant
|
- |
- |
-
|
- |
- |
-
|
ROVI.MC LABORATORIOS FARMACEUTICOS ROVI
|
2.9 billion |
2.07% |
18.88
|
1 |
17 |
30%
|
RPHM Reneo Pharmaceuticals, Inc.
|
43.8 million |
0.00% |
-0.74
|
- |
- |
-
|
RPRX Royalty Pharma plc
Challengers
|
13.8 billion |
2.72% |
16.66
|
4 |
6 |
21%
|
RPTX Repare Therapeutics Inc.
|
44.6 million |
0.00% |
-0.52
|
- |
- |
-
|
RUBY Rubius Therapeutics, Inc.
|
1.7 million |
- |
-2.31
|
- |
- |
-
|
RVMD Revolution Medicines, Inc.
|
6.4 billion |
0.00% |
-9.66
|
- |
- |
-
|
RVNC Revance Therapeutics, Inc.
|
381.0 million |
0.00% |
-
|
- |
- |
-
|
RVPH Reviva Pharmaceuticals Holdings
|
24.7 million |
0.00% |
-0.59
|
- |
- |
-
|
RVPHW Reviva Pharmaceuticals Holdings
|
19.3 million |
0.00% |
-
|
- |
- |
-
|
RXDX Prometheus Biosciences, Inc.
|
9.3 billion |
- |
-9.98
|
- |
- |
-
|
RXRX Recursion Pharmaceuticals, Inc.
|
1.9 billion |
0.00% |
-2.85
|
- |
- |
-
|
RYTM Rhythm Pharmaceuticals, Inc.
|
3.0 billion |
0.00% |
-10.82
|
- |
- |
-
|
RZLT Rezolute, Inc.
|
165.9 million |
0.00% |
-2.23
|
- |
- |
-
|
SABS SAB Biotherapeutics, Inc.
|
11.6 million |
0.00% |
-0.20
|
- |
- |
-
|
SABSW SAB Biotherapeutics, Inc.
|
232222 |
0.00% |
0.09
|
- |
- |
-
|
SAGE Sage Therapeutics, Inc.
|
453.1 million |
0.00% |
-1.12
|
- |
- |
-
|
SANA Sana Biotechnology, Inc.
|
333.0 million |
0.00% |
-1.28
|
- |
- |
-
|
SAVA Cassava Sciences, Inc.
|
62.8 million |
0.00% |
-0.89
|
- |
- |
-
|
SBBP Strongbridge Biopharma plc
|
135.5 million |
- |
-3.29
|
- |
- |
-
|
SBPH Spring Bank Pharmaceuticals, In
|
5.2 million |
- |
-0.81
|
- |
- |
-
|
SBTX Silverback Therapeutics, Inc.
|
206.2 million |
- |
-
|
- |
- |
-
|
SCPH scPharmaceuticals Inc.
|
115.7 million |
0.00% |
-1.20
|
- |
- |
-
|
SCPS Scopus BioPharma Inc.
|
294590 |
- |
-0.02
|
- |
- |
-
|
SEEL Seelos Therapeutics, Inc.
|
429940 |
0.00% |
0.00
|
- |
- |
-
|
SEER Seer, Inc.
|
98.6 million |
0.00% |
-1.19
|
- |
- |
-
|
SELB Selecta Biosciences, Inc.
|
153.4 million |
- |
10.41
|
- |
- |
-
|
SEPN Septerna, Inc. Common Stock
|
257.8 million |
0.00% |
-0.80
|
- |
- |
-
|
SESN Sesen Bio, Inc.
|
119.3 million |
- |
1.91
|
1 |
1 |
-
|
SGEN Seagen Inc.
|
41.2 billion |
6.15% |
-54.52
|
- |
- |
-
|
SGMO Sangamo Therapeutics, Inc.
|
141.5 million |
0.00% |
-1.28
|
- |
- |
-
|
SGTX Sigilon Therapeutics, Inc.
|
18.2 million |
- |
-
|
- |
- |
-
|
SION Sionna Therapeutics, Inc. Commo
|
424.4 million |
0.00% |
-6.88
|
- |
- |
-
|
SIOX Sio Gene Therapies Inc.
|
28.8 million |
- |
-1
|
- |
1 |
-
|
SLDB Solid Biosciences Inc.
|
285.9 million |
0.00% |
-1.21
|
- |
- |
-
|
SLGL Sol-Gel Technologies Ltd.
|
13.1 million |
0.00% |
-
|
- |
- |
-
|
SLN Silence Therapeutics Plc - Amer
|
129.4 million |
0.00% |
-2.77
|
- |
- |
-
|
SLNO Soleno Therapeutics, Inc.
|
3.3 billion |
0.00% |
-16.47
|
- |
- |
-
|
SLRN ACELYRIN, INC.
|
259.8 million |
0.00% |
-1.03
|
- |
- |
-
|
SLRX Salarius Pharmaceuticals, Inc.
|
1.3 million |
0.00% |
-0.13
|
- |
- |
-
|
SLS SELLAS Life Sciences Group, Inc
|
99.9 million |
0.00% |
-2.20
|
- |
- |
-
|
SMMT Summit Therapeutics Inc.
|
13.9 billion |
0.00% |
-61
|
- |
- |
-
|
SMSLIFE.BO SMS Lifesciences India Ltd
|
42.8 million |
0.00% |
15.87
|
- |
4 |
-
|
SMSLIFE.NS SMS LIFESCIENCES (I) LTD
|
42.9 million |
0.00% |
14.48
|
- |
4 |
-
|
SNDX Syndax Pharmaceuticals, Inc.
|
967.8 million |
0.00% |
-3.02
|
- |
- |
-
|
SNGX Soligenix, Inc.
|
7.0 million |
0.00% |
-0.44
|
- |
- |
-
|
SNPX Synaptogenix, Inc.
|
2.8 million |
0.00% |
-0.18
|
- |
- |
-
|
SNSE Sensei Biotherapeutics, Inc.
|
8.2 million |
0.00% |
-0.27
|
- |
- |
-
|
SONN Sonnet BioTherapeutics Holdings
|
3.8 million |
0.00% |
-0.12
|
- |
- |
-
|
SPHS Sophiris Bio, Inc.
|
34 |
- |
0.00
|
- |
- |
-
|
SPPI Spectrum Pharmaceuticals, Inc.
|
266.9 million |
0.00% |
-2.93
|
- |
- |
-
|
SPRB Spruce Biosciences, Inc.
|
4.9 million |
0.00% |
-
|
- |
- |
-
|
SPRC SciSparc Ltd.
|
3.3 million |
0.00% |
-0.06
|
- |
- |
-
|
SPRO Spero Therapeutics, Inc.
|
35.7 million |
0.00% |
-0.50
|
4 |
- |
-
|
SQZ SQZ Biotechnologies Company
|
19.0 million |
- |
-
|
- |
- |
-
|
SRNE Sorrento Therapeutics, Inc.
|
168.4 million |
- |
-4.43
|
- |
- |
-
|
SRPT Sarepta Therapeutics, Inc.
|
5.7 billion |
0.00% |
25.05
|
- |
- |
-
|
SRRA Sierra Oncology, Inc.
|
827.9 million |
- |
-1.06
|
- |
- |
-
|
SRRK Scholar Rock Holding Corporatio
|
2.9 billion |
0.00% |
-12.43
|
- |
- |
-
|
SRZN Surrozen, Inc.
|
36.1 million |
0.00% |
-0.51
|
- |
- |
-
|
SRZNW Surrozen, Inc.
|
331.7 million |
- |
-
|
- |
- |
-
|
STAB Statera Biopharma, Inc.
|
42850 |
0.00% |
-
|
- |
- |
-
|
STOK Stoke Therapeutics, Inc.
|
321.2 million |
0.00% |
-3.60
|
- |
- |
-
|
STRO Sutro Biopharma, Inc.
|
52.8 million |
0.00% |
-0.21
|
- |
- |
-
|
STSA Satsuma Pharmaceuticals, Inc.
|
34.8 million |
0.72% |
-1.58
|
3 |
- |
-
|
STTK Shattuck Labs, Inc.
|
35.1 million |
0.00% |
-0.49
|
- |
- |
-
|
SUPRIYA.BO Supriya Lifescience Limited
|
670.5 million |
0.00% |
32.81
|
- |
3 |
-
|
SUPRIYA.NS SUPRIYA LIFESCIENCE LTD
|
669.0 million |
0.00% |
32.81
|
- |
3 |
-
|
SURF Surface Oncology, Inc.
|
37.6 million |
- |
0.98
|
- |
- |
-
|
SVA Sinovac Biotech Ltd.
|
642.4 million |
2.82% |
6.66
|
- |
- |
-
|
SVRA Savara, Inc.
|
491.1 million |
0.00% |
-5.93
|
- |
- |
-
|
SWTX SpringWorks Therapeutics, Inc.
|
3.2 billion |
0.00% |
-12.38
|
- |
- |
-
|
SYBX Synlogic, Inc.
|
14.0 million |
0.00% |
-0.62
|
- |
- |
-
|
SYN Synthetic Biologics, Inc.
|
134.7 million |
- |
-0.48
|
- |
- |
-
|
SYNGENE.BO Syngene International Limited
|
3.4 billion |
0.15% |
58.15
|
- |
3 |
-
|
SYNGENE.NS SYNGENE INTERNATIO
|
3.4 billion |
0.15% |
58.16
|
- |
3 |
-
|
SYRS Syros Pharmaceuticals, Inc.
|
649347 |
0.00% |
-0.01
|
- |
- |
-
|
TALS Talaris Therapeutics, Inc.
|
125.7 million |
- |
-
|
- |
- |
-
|
TARA Protara Therapeutics, Inc.
|
159.0 million |
0.00% |
-1.99
|
- |
- |
-
|
TARS Tarsus Pharmaceuticals, Inc.
|
2.0 billion |
0.00% |
-15.81
|
- |
- |
-
|
TBPH Theravance Biopharma, Inc.
|
445.7 million |
0.00% |
-7.83
|
- |
- |
-
|
TCDA Tricida, Inc.
|
2.4 million |
- |
-1.20
|
- |
- |
-
|
TCON TRACON Pharmaceuticals, Inc.
|
109725 |
0.00% |
0.01
|
- |
- |
-
|
TCRR TCR2 Therapeutics Inc.
|
77.7 million |
- |
-11.16
|
- |
- |
-
|
TCRT Alaunos Therapeutics, Inc.
|
4.8 million |
0.00% |
-0.01
|
- |
- |
-
|
TCRX TScan Therapeutics, Inc.
|
71.9 million |
0.00% |
-1.11
|
4 |
- |
-
|
TECH Bio-Techne Corp
|
8.8 billion |
0.44% |
56.69
|
4 |
18 |
13%
|
TENX Tenax Therapeutics, Inc.
|
23.8 million |
0.00% |
-5.22
|
- |
- |
-
|
TERN Terns Pharmaceuticals, Inc.
|
183.3 million |
0.00% |
-1.87
|
- |
- |
-
|
TFFP TFF Pharmaceuticals, Inc.
|
722882 |
0.00% |
-
|
- |
- |
-
|
TGTX TG Therapeutics, Inc.
|
5.9 billion |
0.00% |
249
|
- |
- |
-
|
THRD Third Harmonic Bio, Inc.
|
161.0 million |
0.00% |
-3.28
|
- |
- |
-
|
THRX Theseus Pharmaceuticals, Inc.
|
181.3 million |
0.00% |
-3.03
|
3 |
- |
-
|
THTX Theratechnologies Inc.
|
123.1 million |
0.00% |
-
|
- |
- |
-
|
TIL Instil Bio, Inc.
|
95.3 million |
0.00% |
-1.28
|
- |
- |
-
|
TITANBIO.BO TITAN BIOTECH LTD.
|
45.9 million |
0.00% |
17.45
|
1 |
5 |
10%
|
TLC Taiwan Liposome Company, Ltd.
|
294.5 million |
- |
-5.13
|
- |
- |
-
|
TLOG TetraLogic Pharmaceuticals Corporation
|
458720 |
4.85% |
-0.02
|
- |
- |
-
|
TLSA Tiziana Life Sciences Ltd
|
112.9 million |
0.00% |
-7.85
|
- |
- |
-
|
TMBR Timber Pharmaceuticals, Inc.
|
1.3 million |
- |
-0.05
|
- |
- |
-
|
TNGX Tango Therapeutics, Inc.
|
137.3 million |
0.00% |
-1.07
|
- |
- |
-
|
TNXP Tonix Pharmaceuticals Holding C
|
116.1 million |
0.00% |
-
|
- |
- |
-
|
TPST Tempest Therapeutics, Inc.
|
27.9 million |
0.00% |
-0.41
|
- |
- |
-
|
TPTX Turning Point Therapeutics, Inc.
|
3.8 billion |
- |
-31.45
|
- |
- |
-
|
TRDA Entrada Therapeutics, Inc.
|
301.5 million |
0.00% |
4.77
|
- |
- |
-
|
TRIL Trillium Therapeutics Inc.
|
1.9 billion |
5.56% |
-10.91
|
- |
- |
-
|
TRML Tourmaline Bio, Inc.
|
330.3 million |
- |
-4.45
|
- |
- |
-
|
TRVI Trevi Therapeutics, Inc.
|
607.2 million |
0.00% |
-13.36
|
- |
- |
-
|
TRVN Trevena, Inc.
|
1.1 million |
0.00% |
-0.03
|
- |
- |
-
|
TSHA Taysha Gene Therapies, Inc.
|
262.4 million |
0.00% |
-3.56
|
- |
- |
-
|
TSVT 2seventy bio, Inc.
|
260.1 million |
0.00% |
-4.52
|
- |
- |
-
|
TTNP Titan Pharmaceuticals, Inc.
|
3.7 million |
0.00% |
-0.77
|
- |
- |
-
|
TUB.BR TUBIZE-FIN
|
5.9 billion |
0.63% |
57.72
|
1 |
26 |
30%
|
TVTX Travere Therapeutics, Inc.
|
1.3 billion |
0.00% |
-3.68
|
- |
- |
-
|
TYME Tyme Technologies, Inc.
|
53.5 million |
- |
-4.02
|
- |
- |
-
|
TYRA Tyra Biosciences, Inc.
|
421.2 million |
0.00% |
-5.50
|
- |
- |
-
|
UBX Unity Biotechnology, Inc.
|
16.7 million |
0.00% |
-0.64
|
- |
- |
-
|
UCB.BR UCB
|
33.1 billion |
0.73% |
27.98
|
1 |
26 |
-15%
|
UCBJF UCB S.A.
|
23.2 billion |
0.01% |
64.21
|
- |
- |
-
|
UCBJY UCB S.A. UNSP ADR EACH REPR 0.5
|
29.6 billion |
1.02% |
25.21
|
1 |
15 |
-
|
UNCY Unicycive Therapeutics, Inc.
|
60.5 million |
0.00% |
-1.10
|
- |
- |
-
|
UPB Upstream Bio, Inc.
|
337.9 million |
0.00% |
-1.13
|
- |
- |
-
|
URGN UroGen Pharma Ltd.
|
433.0 million |
0.00% |
-3.47
|
- |
- |
-
|
UTHR United Therapeutics Corporation
|
13.1 billion |
0.00% |
11.82
|
- |
- |
-
|
VACC Barinthus Biotherapeutics plc
|
192.7 million |
- |
15.64
|
- |
- |
-
|
VALN Valneva SE
|
485.5 million |
0.00% |
-35.17
|
- |
- |
-
|
VAXX Vaxxinity, Inc.
|
25357 |
0.00% |
-1.34
|
- |
- |
-
|
VBIV VBI Vaccines, Inc.
|
1.9 million |
0.00% |
-
|
1 |
- |
-
|
VBLT Vascular Biogenics Ltd.
|
15.0 million |
8.81% |
-2.03
|
- |
- |
-
|
VCEL Vericel Corporation
|
2.1 billion |
0.00% |
209.60
|
- |
- |
-
|
VCNX Vaccinex, Inc.
|
1.6 million |
0.00% |
0.08
|
- |
- |
-
|
VECT VectivBio Holding AG
|
799.9 million |
- |
-
|
- |
- |
-
|
VERA Vera Therapeutics, Inc.
|
1.4 billion |
0.00% |
-7.75
|
- |
- |
-
|
VERU Veru Inc.
|
87.8 million |
0.00% |
-2.86
|
4 |
- |
-
|
VERV Verve Therapeutics, Inc.
|
321.4 million |
0.00% |
-1.54
|
- |
- |
-
|
VIGL Vigil Neuroscience, Inc.
|
77.9 million |
0.00% |
-0.81
|
- |
- |
-
|
VINC Vincerx Pharma, Inc.
|
3.5 million |
0.00% |
-0.04
|
- |
- |
-
|
VIR Vir Biotechnology, Inc.
|
817.4 million |
0.00% |
-1.56
|
- |
- |
-
|
VIRI Virios Therapeutics, Inc.
|
4.7 million |
0.00% |
-2.54
|
- |
- |
-
|
VIRX Viracta Therapeutics, Inc.
|
874372 |
0.00% |
-0.02
|
- |
- |
-
|
VKTX Viking Therapeutics, Inc.
|
2.5 billion |
0.00% |
-22.40
|
- |
- |
-
|
VLA.PA VALNEVA SE
|
595.1 million |
0.00% |
-40.27
|
- |
- |
-
|
VNDA Vanda Pharmaceuticals Inc.
|
254.8 million |
0.00% |
-13.24
|
- |
- |
-
|
VOR Vor Biopharma Inc.
|
73.7 million |
0.00% |
-0.35
|
- |
- |
-
|
VRCA Verrica Pharmaceuticals Inc.
|
48.7 million |
0.00% |
-0.36
|
- |
- |
-
|
VRNA Verona Pharma plc
|
4.9 billion |
0.00% |
-26.89
|
- |
- |
-
|
VRPX Virpax Pharmaceuticals, Inc.
|
831854 |
0.00% |
-0.01
|
- |
- |
-
|
VRTX Vertex Pharmaceuticals Incorpor
|
124.2 billion |
0.00% |
-232.45
|
- |
- |
-
|
VSTM Verastem, Inc.
|
265.7 million |
0.00% |
-1.41
|
- |
- |
-
|
VTGN VistaGen Therapeutics, Inc.
|
65.8 million |
0.00% |
-1.54
|
- |
- |
-
|
VTVT vTv Therapeutics Inc.
|
45.7 million |
0.00% |
-5.47
|
- |
- |
-
|
VTYX Ventyx Biosciences, Inc.
|
71.8 million |
0.00% |
-0.51
|
- |
- |
-
|
VXRT Vaxart, Inc. - Common Stock
|
86.4 million |
0.00% |
-1.15
|
- |
- |
-
|
VYGR Voyager Therapeutics, Inc.
|
171.7 million |
0.00% |
-2.75
|
- |
- |
-
|
VYNE VYNE Therapeutics Inc.
|
24.3 million |
0.00% |
-1.72
|
- |
- |
-
|
VYNT Vyant Bio, Inc.
|
1.2 million |
- |
0.65
|
- |
- |
-
|
WINT Windtree Therapeutics, Inc.
|
880477 |
0.00% |
0.88
|
- |
- |
-
|
WVE Wave Life Sciences Ltd.
|
1.0 billion |
0.00% |
-9.49
|
- |
- |
-
|
WXIBF WuXi Biologics (Cayman) Inc.
|
25.6 billion |
- |
46.31
|
- |
- |
-
|
WXXWY Wuxi Biologics (Cayman) Inc
|
13.0 billion |
0.00% |
30.10
|
- |
- |
-
|
XBIO Xenetic Biosciences, Inc.
|
3.8 million |
0.00% |
-0.96
|
- |
- |
-
|
XBIT XBiotech Inc.
|
85.4 million |
0.00% |
-2.22
|
- |
- |
-
|
XCUR Exicure, Inc.
|
82.1 million |
0.00% |
-2.74
|
- |
- |
-
|
XENE Xenon Pharmaceuticals Inc.
|
2.4 billion |
0.00% |
-10.45
|
- |
- |
-
|
XERS Xeris Biopharma Holdings, Inc.
|
751.2 million |
0.00% |
-13.19
|
- |
- |
-
|
XFOR X4 Pharmaceuticals, Inc.
|
36.5 million |
0.00% |
-1.11
|
- |
- |
-
|
XLO Xilio Therapeutics, Inc.
|
36.7 million |
0.00% |
-
|
- |
- |
-
|
XLRN Acceleron Pharma Inc.
|
10.9 billion |
- |
-41.22
|
- |
- |
-
|
XNCR Xencor, Inc.
|
612.3 million |
0.00% |
-2.43
|
- |
- |
-
|
XOMA XOMA Royalty Corporation
|
233.4 million |
0.00% |
-12.01
|
- |
- |
-
|
XOMAO XOMA Royalty Corporation - Depo
|
303.2 million |
8.23% |
25.28
|
4 |
5 |
-
|
XOMAP XOMA Royalty Corporation - 8.62
|
306.7 million |
8.37% |
25.57
|
4 |
5 |
30%
|
XRTX XORTX Therapeutics Inc.
|
3.6 million |
0.00% |
-0.83
|
- |
- |
-
|
XTLB XTL Biopharmaceuticals Ltd.
|
11.2 million |
0.00% |
-6.35
|
- |
- |
-
|
YECO EV Biologics, Inc.
|
6.1 million |
- |
-0.49
|
- |
- |
-
|
YMAB Y-mAbs Therapeutics, Inc.
|
200.3 million |
0.00% |
-6.61
|
- |
- |
-
|
YMTX Yumanity Therapeutics, Inc.
|
22.0 million |
- |
-
|
1 |
1 |
-
|
ZEAL Zealand Pharma A/S
|
814.1 million |
- |
-13.97
|
- |
- |
-
|
ZGNX Zogenix, Inc.
|
892.0 million |
- |
-3.56
|
- |
- |
-
|
ZIOP ZIOPHARM Oncology, Inc.
|
220.5 million |
- |
-7.57
|
- |
- |
-
|
ZIVO Zivo Bioscience, Inc.
|
59.2 million |
0.00% |
-3.72
|
- |
- |
-
|
ZIVOW Zivo Bioscience, Inc.
|
35.3 million |
0.00% |
-
|
- |
- |
-
|
ZLAB Zai Lab Limited
|
357.5 million |
0.00% |
-12.70
|
- |
- |
-
|
ZNTL Zentalis Pharmaceuticals, Inc.
|
97.3 million |
0.00% |
-0.58
|
- |
- |
-
|
ZOTA.NS ZOTA HEALTH CARE LIMITED
|
261.8 million |
0.00% |
-43.29
|
- |
8 |
4%
|
ZSAN Zosano Pharma Corporation
|
66.0 million |
- |
-0.33
|
- |
- |
-
|
ZYME Zymeworks Inc.
|
817.5 million |
0.00% |
-7.25
|
- |
- |
-
|